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ABSTRACT 
Scurfy is an X-linked recessive disorder in mice characterized by the accumulation of 
activated lymphocytes in the peripheral lymphoid organs, culminating in early lethality 
due to severe wasting and cytokine toxicity. The gene(s) responsible for the scurfy 
phenotype are unknown, but the massive lymphoproliferation implies a loss of immune 
tolerance. Although a defect in thymic selection has not been excluded, the phenotype 
is more consistent with a polyclonal activation of the peripheral immune system. We 
have examined two pathways that have been documented to maintain peripheral 
lymphocyte homeostasis, the Fas-FasL pathway and the CD28/CTLA-4/B7 pathway. The 
Fas pathway is responsible for the activation-induced cell death (AICD) of lymphocytes 
at the termination of an immune response. It plays a critical role in restoring lymphocyte 
homeostasis and limiting the potentially deleterious effects of prolonged cytokine 
secretion. Mice with defects in the Fas-FasL pathway exhibit severe lymphoproliferation 
and autoimmune disease. In addition to the apoptotic pathway mediated by Fas-FasL, 
signalling through the CTLA-4 T cell receptor provides a negative regulatory signal to 
T cells, blocking cell cycle progression. In the absence of CTLA-4, the peripheral 
immune system is massively activated, leading to a lymphoproliferative phenotype very 
similar to scurfy. Our data suggest that both the Fas-FasL and CD28/CTLA-4/B7 
pathways are activated in scurfy mice. Although scurfy lymphocytes demonstrate 
evidence of previous and recent activation, have upregulated Fas mRNA, Fas cell surface 
expression, and FasL mRNA, we detect negligible levels of apoptosis in freshly isolated 
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scurfy lymphocytes. It is unclear why activated lymphocytes that are phenotypically­
primed for apoptosis are accumulating in scurfy peripheral lymphoid organs. However, 
our data excludes an intrinsic defect in the Fas apoptotic pathway. If provided with an 
exogenous signal through the Fas receptor, scurfy lymphocytes rapidly and spontaneously 
undergo apoptosis. 
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Part 1 
General Introduction and Background Information 
Chapter 1 
General Introduction 
Scurfy (sf) is an X-linked mutation that occurred spontaneously at the Oak Ridge National 
Laboratory in 1949. The mutation causes a T cell lymphoproliferative disorder that is 
lethal in hemizygous males by 24 days of age. Although several other mutations cause 
lympboproliferation disorders in mice, scurfy manifests the most severe disease phenotype 
described to date. Scurfy maps to the centromeric portion of the X chromosome within 
2 centimorgans ( cM) of sparse fur (spf), a mutation in the ornithine transcarbamylase gene 
(Otc) (Godfrey et al. , 1991; Veres et al., 1987). This region is homologous to human 
chromosome region Xp21.1-Xpl 1.23, to which the gene for human Wiskott-Aldrich 
Syndrome (WAS) maps (Larval and Boyd, 1993). Because ofhomologous map positions 
and a number of phenotypic similarities, scurfy was a candidate gene for WAS. 
However, the defective gene, WASP (Wiskott-Aldrich Syndrome protein), was cloned in 
1994, and scurfy mice show no mutations in the homologous murine gene (Derry et al., 
1994; Godfrey, V., personal communication). The causative gene(s) responsible for the 
scurfy phenotype are still •nknown. 
The scurfy disease primarily affects the lymphoreticular system, although there is 
lymphocyte infiltration of other organ systems. The scurfy phenotype is first apparent by 
a swelling and reddening of the genital papilla at 12-14 days of age, followed by a 
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scaliness of the ears, feet, tail, and eyelids. The mutants develop graft-versus-host-disease 
(GVHD)-like lesions, leading to a severe wasting disease that culminates in death by 24 
days of age (Godfrey et al., 1991 .) The gross pathology of the scuify mouse was 
described by V.L. Godfrey in 1991 and includes: an enlarged liver with necrotic lesions, 
scaly skin, anemia, enlarged peripheral lymph nodes, and splenomegaly. A bilobed 
thymus is initially present, but it is progressively depleted of thymocytes with disease 
progression and age. Histologically, the scuify mouse is characterized by infiltration of 
the dermis with a population of pleomorphic leukocytes, complete loss of normal lymph 
node architecture, and expansion of the spleen by hematopoietic cells. Scuify mice also 
exhibit a polyclonal increase in serum immunoglobulins, and overexpress mRNA and 
protein for most cytokines tested (Godfrey, 1991 ; Blair et al., 1994). 
Initial experiments were conducted to examine the role of the thymus in scuify disease. 
Mice bred to be both scuify and nude (sf/Y; nu/nu) or scuify and severe combined 
immunodeficient (s.f/Y; scidlscid) showed no signs of scuify disease. Nude mice are born 
without a thymus, and therefore have no mature T lymphocytes (Stromminger, 1989). 
Seid mice have a defect in DNA repair that results in non-productive rearrangement of 
T cell receptor and immunoglobulin genes (Stomminger, 1989). Because of this defect, 
scid mice have few mature T or B lymphocytes. The lack of scuify disease in mice with 
no mature T cells suggested that this population of cells must mediate scuify disease 
(Godfrey et al., 1991). 
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The breeding experiments indicated that mature T cells mediate scwfy disease, but did 
not address whether this defect was already present in the precursor stem cell populations 
of the bone marrow. Therefore, scurfy bone marrow was transferred to lethally irradiated 
congenic or H-2 compatible nonnal mice. Although donor scurfy bone marrow was 
capable of reconstituting the recipient, scurfy disease was not transmitted. From these 
experiments, it was concluded that scurfy is mediated by T cells that must mature in a 
scurfy thymic microenvironment (Godfrey et al., 1991 ). 
Totipotent hematopoietic stem cells migrate from the bone marrow and fetal liver to the 
thymus where they undergo differentiation into mature T cells. To detennine if scurfy 
thymocytes can transfer disease, scurfy thymi were grafted to congenic euthymic 
(immunocompetent) mice, nude mice, and scid mice. Grafting a scurfy thymus to a 
congenic wild-type recipient did not transmit scurfy disease. In contrast, grafting a scurfy 
thymus to congenic nude or scid recipients resulted in morphological lesions characteristic 
of scurfy . Additionally, injection ofscurfy thymocytes, lymph node cells, and splenocytes 
into H-2 compatible nude or scid mice resulted in transmission of scuify disease (Godfrey 
et al., 1994). This data was interpreted to mean that scurfy disease can be suppressed or 
inhibited in euthymic recipient mice. 
It was established that mature T cells mediate scurfy disease (Godfrey et al., 1994). 
However, this population can be divided into two functionally distinct subsets, 
distinguished by their expression of the coreceptors CD4 or CDS (von Boehmer, 1988). 
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CD4+ T cells recognize antigen bound to class II major histocompatibility complex 
(MHC) molecules. CD4+ T cells are considered 'helper' T cells in that their primary 
function is to secrete cytokines which induce effector functions in B cells and other 
hematopoietic cells (Coffman et al., 1988). The other T cell subset is defined by the CD8 
cell surface receptor. CD8+ T cells recognize antigen in the context of class 1 MHC 
molecules, and are important in the cytotoxic killing of virally-infected cells and other 
intracellular pathogens (Teh et al., 1988). To determine if one of these functional subsets 
was mediating scurfy disease, double mutant scurfy-spa-rsefur (sf spf/Y) neonates were 
injected with either anti-CD4 or anti-CDS monoclonal antibodies (mAbs) to deplete the 
respective subset population. The double mutants were used because scurfy disease is not 
physically apparent tmtil 12 days, whereas the sf spf/Y mutants can be identified by 
polymerase chain reaction (PCR) assay at birth. Injection ofanti-CD8 antibodies, leaving 
only CD4+ T cells, resulted in no change in disease progression. However, depletion of 
the CD4+ subset, leaving only CD8+ T cells, ameliorated disease lesions and prolonged 
lifespan. Scurfy disease was not completely prevented in anti-CD4 mAb treated sfspf/Y 
mice because they became immunologically resistant to the mAb treatment. This allowed 
CD4+ T cells to eventually develop and to induce scurfy disease. To generate scurfy­
spa-rsefur mice completely lacking one T cell subset, the scurfy-sparsefur mutation was 
bred onto 132-microglobulin (lacking CD8+ T cells) and CD4-deficient transgenic mouse 
lines. 132-microglobulin-deficient sf spf/Y mice exhibited little moderation in disease, 
where as CD4-deficient sfspf/Y mice had prolonged life span and reduced scurfy lesions. 
The final conclusive evidence identifying the CD4+ T cell subset as the mediator of 
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scurfy disease came from adoptive transfer experiments. Adoptive transfer of scurfy 
CD4+CD8- T cells, but not CD4-CD8+ T ce11s, into H-2 compatible nude mice 
transplanted scurfy disease. Therefore, all evidence points to the CD4+ T cell subset as 
the mediators of scurfy disease, although in the absence ofCD4+ T cells, other cell types 
must gain 'helper' functions since even CD4-less ~f spfl Y mice ultimately succumb to 
scurfy disease (Blair et al., 1994). The overall phenotype of scurfy mice suggests a 
massive activation of the peripheral immune system, leading to uncontrolled 
lymphoproliferation and secretion of toxic levels of inflammatory cytokines, culminating 
in early lethality. 
Research Goals 
The goal of this research project was to investigate two pathways that have been 
identified to play a role in maintaining peripheral lymphocyte homeostasis, the Fas-FasL 
pathway (described in Part 2) and the CD28/CTLA-4/B7 pathway (described in Part 3). 
Mice with defects in these pathways exhibit phenotypic similarities to scurfy mice, 
particularly mice in which the CTLA-4 pathway has been completely knocked out (Chu 
et al., 1993; Takahashi et al., 1994; Tivol et al., 1995; Waterhouse et al., 1995). 
Therefore we wanted to examine the expression and function of these pathways in the 
scurfy mutant mouse in an attempt to localize the scurfy protein within known lymphoid 
signalling pathways. Relating scurfy to defective signalling in the Fas/FasL or 
CD28/CTLA-4/B7 pathways could help to identify the scurfy gene. 
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In multicellular organisms, cell death can be either random or programmed. The 
morphology of cells undergoing random death is described as necrotic, where as that of 
cells undergoing programmed cell death (PCD) is usually, but not always, apoptotic. The 
term 'apoptosis' is often incorrectly used interchangeably with programmed cell death. 
PCD originally implied that cell death occurred within a developmental context, and 
unlike necrosis, PCD required de novo gene expression (Schwartz and Osborne, 1993). 
However, the tenn apoptosis describes a fonn of cell death that can be morphologically 
distinguished from necrotic cell death , and may or may not occur in a developmental 
context. Necrosis describes the morphology of cells dying from massive cell ular injury 
(Lennon et al., 1991). Necrotic cells are characterized by an early swelling of the 
mitochondria, rnpture of the plasma membrane, and subsequent release of the cytoplasmic 
contents. The release of cellular components into the intercellular space often leads to 
the inflammatory responses observed after necrosis (Darzynkiewicz et al., 1994). In 
contrast, apoptotic cells are characterized by nuclear chromatin condensation, no Joss of 
plasma membrane integrity, and activation of an endogenous endonuclease which cleaves 
intemucleosomal DNA linker regions. When examined by gel electrophoresis, the cleaved 
DNA produces the characteristic DNA "ladder" that has been considered the hallmark of 
apoptosis (Wyllie et al., 1984). During apoptosis, the plasma membrane pinches off into 
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membrane-bound apoptotic bodies which are phagocytized before their cellular contents 
are released. Therefore, apoptosis does not generally lead to inflammation and secondary 
tissue damage. Because apoptotic cells retain their plasma membrane integrity, they 
exclude vital dyes that are often used to characterize dying cells (Darzynkiewicz et al., 
1992). 
The Role of Apoptosis in the Immune System 
Central Tolerance 
Apoptotic cell death plays a pivotal role in maintaining tolerance and cellular homeostasis 
in the immune system. This is particularly well documented with tbymic-derived or T 
lymphocytes. It has long been established that central ( or intrathymic) tolerance is 
maintained by the apoptosis of developing thymocytes through the processes of positive 
and negative selection. Immature T cells that recognize self major histocompatibility 
complex (MHC) are positively selected, while those that do not, die by apoptosis (Von 
Boehmer, 1994). Among immature T cells that survive positive selection, those that are 
strongly reactive to self-components in the thymus are deleted by apoptosis through a 
process tenned negative selection (Nossal, 1994). Immature T cells that survive both 
positive and negative selection continue to differentiate into mature single-positive CD4 
or CD8 T cells which are exported to the periphery. This strict selection process is 
necessary to release only mature, self-restricted, self-tolerant, antigenically-reactive T cells 
into the periphery. Evidence suggests that only 5% ofdeveloping thymocytes are released 
into the periphery, while the remainder perish in the thymus (Surb and Sprent, 1994). 
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Peripheral Tolerance 
Once mature T cells migrate to the peripheral lymphoid organs • they are fully capable 
of responding to antigenic stimulation. In the presence of a costimulatory signal, ligation 
of the T cell receptor (TcR) of mature T cells. either by foreign antigens or self-antigens 
that were not encountered in the thymus, results in their activation. The activated T cells 
proliferate into a large pool of effector clones capable of producing potentially toxic 
levels of inflammatory cytokines. Therefore, mechanisms must also exist in the periphery 
to control lymphocyte expansion during an immune response, as well as maintain 
tolerance to self-antigens encountered in the periphery. This is referred to as peripheral 
(or extrathymic) tolerance and evidence strongly suggests that this process may proceed 
through an apoptotic mechanism (Jones et al., 1990). 
Until recently, in vitro evidence suggested that apoptosis was restricted to the immature 
T cell populations undergoing differentiation in the thymus, and that mature single­
positive T cells were largely resistant to the induction of apoptosis. This view was 
supported by the fact that many of the same stimuli that induced apoptosis in immature 
T cells, induced activation and proliferation in mature T cells (K.abelitz et al., 1993). For 
example, ligation of the TcR of immature T cells with either antigen or anti-CD3 
antibodies causes the cells to undergo apoptosis. Ligation of the TcR, of mature 
peripheral T cells results in their activation and subsequent clonal expansion into effector 
cells capable of secreting cytokines and stimulating antibody production (Russell et al. , 
1991 ). However, it has been discovered that the activation state of a mature T cell plays 
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a major role in detennining its susceptibility to apoptosis. It appears that mature resting 
T cells are largely resistant to apoptosis, while mature activated T cells are susceptible 
(Russell et al. , 1991). Apoptosis of mature T cells by repeated activation is tenned 
activation-induced cell death (AICD) and is thought to limit the expansion oflymphocytes 
during an immune response, and to delete autoreactive cells that have escaped thymic 
selection (Lynch et al. , 1995). AICD occurs through an apoptotic pathway mediated by 
the Fas/FasL association (Van Parijs et al., 1996). 
Fas/FasL (lprApr and gldlgld) 
Historically, thymic deletion has been considered to be the primary mechanism involved 
in the maintenance of immune tolerance . But a number of genes have been identified 
which are thought to play a role in peripheral deletion, but not thymic selection (Singer 
and Abbas, 1994). Mice with mutations in these genes have severe immune dysfunction, 
thereby supporting the crucial role of peripheral deletion in the maintenance of immune 
tolerance. 
Two autosomal recessive, non-allelic mouse mutations, /pr (lymphoproliferation) and gld 
(generalized lymphoproliferative disease), have been identified that represent defects in 
a receptor-ligand pair that appear to play a sign ificant role in lymphocyte homeostasis and 
the activation-induced cell death of mature peripheral T cells (Russe11 et al., 1993; Singer 
and Abbas, 1994). The mouse !pr locus is found on chromosome 19, and the gld locus 
has been mapped to mouse chromosome 1 (Watanabe-Fukunaga et al., 1992; Takahash i 
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et al.,1994). MRL-lprl/pr and "MR.L-gldlgld mutants are characterized by autoimmune 
disease and progressive lymphadenopathy and splenomegaly that are reminiscent of 
human systemic lupus erythematosus (SLE) (Andrews et al., 1978). The severity of both 
the autoimmunity and the lymphoproliferation are highly influenced by genetic 
background, with the most severe phenotype manifested in the MRL-strain (Izui et al., 
1984). The modifying genes have not been identified and their role in accelerating 
autoimmunity is not understood (Cohen and Eisenberg, 1991). ln addition, /pr and gld 
mice accumulate a non-neoplastic, non-proliferating subset of thymus-derived T cells, 
referred to 'double-negative T cells'. They are a /13-TcR+, but lack both CD4 and CD8 
coreceptors, and express the B cell marker, B220. This abnormal subset is detected in 
the lymph nodes of mutant mice by 4 weeks of age, and may comprise up to 90% of the 
T cells in the lymph nodes by 6 months of age (Wofsy et al., 1984). 
In 1993, it was discovered that the defect in !pr mice was a loss-of-function mutation 
resulting from the insertion of an early transposable element (ETn) into intron 2 of the 
Fas (fibroblast-associated) gene, a gene involved in apoptosis (Chu el al. 1993). The ETn 
contains a polyadenylation signal which causes premature termination of transcription. 
As a result, very little full-length Fas mRNA and surface protein are detectable in /pr 
homozygous mice (Chu et al., 1993). The g/d mutation is a single amino acid substitution 
in the Fas ligand (FasL ) gene, which prevents its binding to the Fas receptor and 
transducing the apoptotic signal (Takahashi et al., 1994). An additional mutation allelic 
to /pr, lpfi, results from a point mutation in the intracellular domain of the Fas receptor. 
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This mutation blocks transmission of the apoptotic signal by Fas, resulting in a phenotype 
very similar to /pr and gld (Krammer et al., 1994). 
Fas is a type I transmembrane protein that belongs to the tumor necrosis factor (TNF) / 
nerve growth factor (NGF) superfamily of receptors (Watanabe-Fukunaga et al. , 1992). 
Other members include CD27, CD30, CD40, OX40, and 4-lBB, all characterized by 
cysteine-rich sequences within their extracellular domains that are necessary for ligand 
binding. The Fas and TNF receptor I share homology in a 70 amino acid stretch known 
as the 'death domain' which is responsible for transducing the death signal (Tartaglia et 
al., 1993). Fas is expressed primarily on lymphoid cells, as well as on a variety of cell 
types of hemopoietic and epithelial lineages. In addition, Fas expression is upregulated 
upon activation (Nishim ura et al., 1995) The FasL is a type 11 membrane protein and is 
a member of the INF family, which includes TNF-alpha, LT-alpha, LT-beta, CD27L, 
CD30L, and CD40L (Suda et al., 1993). The expression of FasL is restricted to activated 
mature T cells, and is constitutively expressed io the immunologically privileged tissues 
of the eye and testis (Suda el al., 1995; Suda et al., 1993). Both Fas and FasL can also 
exist as soluble proteins by proteolytic cleavage of their transmembrane domains, and 
some fonns of soluble Fas are thought to block Fas-mediated apoptosis (Hughes and 
Crispe, J995; Cascino et al., 1995; Tanaka et al., 1995). Even though Fas is expressed 
in tissues outside of the lymphoid system, defects in the Fas-FasL system appear to 
primarily affect the immune system (Krammer et al., 1994). 
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Fas-mediated apoptosis can be induced by binding of the Fas receptor to the soluble or 
membrane-bound FasL, or by crosslinking the Fas receptor with either anti-Fas or anti­
FasL monoclonal antibodies (mAbs). Fas expression alone is not sufficient to ·induce 
apoptosis and signai transduction through Fas is thought to require receptor trimerization 
(Ohein et al. , 1992). The exact nature of the biochemical pathway(s) that Fas signals 
through have not been elucidated, although a number of proteins that interact with the 
cytoplasmic domain of Fas have been identified using the yeast two-hybrid system 
(Chinnaiyan et al., 1995; Stanger et al., 1995). 
The roles of Fas and FasL in apoptosis suggested that perhaps the phenotypes of /pr and 
gld mice resulted from defects in thym1c selection. Uefective negative selection would 
release autoreactive lymphocytes into the periphery where they induce autoimmunity and 
lymphoproliferation. Fas is constitutively expressed on the immature C04+CU8+ 
thymocytes, the population that is susceptible to thymic selection. In 1995, it was 
demonstrated that treatment of CD4+CD8+ thymocytes with anti-Fas mAbs resulted in 
apoptosis both in vitro and in vivo (Ogasawara et al., 1995). However, all evidence to 
date suggests that thymic selection is intact in lpr and gld mutants (Herron et al. , l 993 ). 
The most convincing evidence comes from /pr mice expressing a transgene-derived TcR 
specific for a known peptide. In these experiments, injection of the peptide induced 
deletion of thymocytes but not of mature peripheral T cells (Singer and Abbas, 1994). 
Therefore , it is currently thought that Fas does not play an obligatory role in thymic 
selection. Because /pr mice do express very low levels of Fas, there was some question 
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as to whether there was enough wild-type Fas to maintain normal thymic selection in 
these mice. This possibility was conclusively excluded by the creation of Fas-null (Fas-/-) 
mice by targeted deletion of the Fas gene (Adachi et al. 1995). Compared with !pr 
mutants, the Fas-/- mice exhibited enhanced and accelerated lymphoproliferation. In 
addition, injection of the superantigen staphylococcal enterotoxin (SEB), which reacts 
with Vl38 TcR's, caused deletion of immature thymocytes but not of mature peripheral T 
cells in the Fas-/- mice (Osborne, 1996). In vitro experiments also show that activated 
mature T cells from /pr mice are refractory to AICD induced by a number of stimuli that 
cause apoptosis in activated mature wild-type T cells (Gillette-Ferguson and Sidman, 
1994). Therefore all evidence points to a primary role for Fas-FasL in the peripheral 
AICD of mature T cells. 
Resean:b Goals 
The lymphoproliferative phenotype of scwfy mice is suggestive ofa breakdown in central 
and/or peripheral immune tolerance. A defect in central tolerance would likely result in 
the escape of potentially autoreactive T cells into the periphery, where they would 
proliferate in response to chronic stimulation from self-antigens encountered there. 
Misguided help from autoreactive T cells could lead to the production of autoantibodies, 
which would be detectable in sf serum. However, Godfrey et al. (1991) did not detect 
anti-nuclear antibodies for ribonuclear proteins (RNP), double-stranded DNA (dsDNA), 
or the small ribonuclear protein antigens SM, Ro, and La in sf sera. On the other hand, 
a defect in a mechanism involved in maintaining peripheral tolerance could also result in 
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the accumulation ofactivated cells in the peripheral lymphoid organs. Therefore, the goal 
of this research was to examine the expression and function of the Fas-FasL apoptotic 
pathway in scurfy mice. 
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Chapter 2 
Methods and Materials 
Mice 
The scurfy (sf) mutation is maintained on a noninbred stock (DG) by mating scurfy 
carrier females (X-X'1) to (C3Hf/RI x 101/Rl)Fl or (10 1/RI x C3Hf/Rl)F l males. Sparse­
fur (spj) is an X-linked mutation in the ornithine transcarbamylase gene, located 
approximately 2-4 centimorgans (cM) from sf The scurfy sparse-fur (sf spf) double 
mutation is maintained on a noninbred background by mating sf spf carrier females to 
(C3Hf/Rl x 101/Rl)F l or (101/Rl x C3Hf/Rl)Fl males. C3H-lprl lpr (lpr) breeder pairs 
were originally obtained from The Jackson Laboratory (Bar Harbor, ME) and bred at the 
Oak Ridge National Laboratory. All stocks were housed in a conventional environment 
and fed a standard laboratory diet (Purina 5001) and chlorinated water ad libitum . 
Cell Preparations 
Cell suspensions from thymi and lymph nodes (axillary, inguinal , and cervical) were 
prepared by grinding tissue through a sterile 70µm nylon cell strainer (Falcon) on ice, 
followed by washing with cold phosphate-buffered saline (PBS). Cells were then passed 
through a 26-gauge needle to obtain a single-cell suspension. Nucleated cells were 




All antibodies were purchased from Phanningen (San Diego, CA) for flow cytometric 
analysis. Thymocytes were double stained with fluorescein isothiocyanate (FITC)­
conjugated and phycoerythrin (PE)-conjugated primary antibodies to CD4, CDS, CD69 
(Very Early Activation Antigen), CD44 (Pgp-1, Ly-24 ), and CD25 (IL-2 Receptor alpha 
chain, p55). Lymph node cells were double-stained with the following directly-conjugated 
primary antibodies to a /~-TcR, CD45R/B220, CD4, CDS, CD44, CD25, CD62L (L­
selectio, LECAM-1 , Ly-22, MEL-14), CD45RB, CD69, and Fas (CD95). Streptavidin­
phycoerythrin was used as a second step for labelling all biotinylated primary antibodies. 
Flow Cytometric Analysis 
Aliquots of lxl06 cell s in 200µL of FACS buffer (0.1% sodium azide and 0.5% bovine 
serum albumin in PBS) were added to 12x74mm polystyrene tubes (Falcon) on ice. Non­
specific binding of immunoglobulins was blocked by addition of lµL of rat anti-mouse 
antibody specific for the Fe gamma ll/IIl receptor (CD16/CD32) (Phanningen, San Diego, 
CA). Directly conjugated primary antibodies were added at lµg/lx l 06 cells in 200µL 
F ACS buffer and incubated on ice for 30 minutes. Cells were then washed in 2ml of 
F ACS buffer. If the primary antibody was conjugated to biotin, 2µL of streptavidin­
pbycoerythrin was added, the cells stained for 30 minutes on ice and washed again. Cells 
were resuspended in S00µL of F ACS buffer and immediately analyzed on a F ACScan II 
flow cytometer (Becton-Dickinson). At least 10,000 cells were assayed for each sample. 
Dead cells and debris were eliminated by gating on forward and side light scatter patterns 
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during data analysis. 
Lymphocyte Activation for FasL mRNA Expression Analysis 
Splenocytes isolated from wild-type and scurfy mice were activated in vitro with ConA 
(Takahashi et al., 1994). 2xl06 cell/ ml were cultured in 0.5ml RPMl 1640 Complete 
medium ( containing 10% fetal calf serum (FCS), 50mM (3-mercaptoethanol, 1 % 
penicillin/streptomycin., and 1 % L-glutamine) in the presence of 2.5µg/ml ConA. At 48 
hours, cells were collected and RNA isolated for reverse-transcriptase polymerase chain 
reaction (RT-PCR) analysis as described below. 
Reve~e Transcriptase (Rl)-PCR Analysis 
Total RNA was prepared from lymph nodes and tbymi using guanidine isothiocyanate as 
previously described (Chomczynski and Sacchi, 1987). One microgram of total RNA was 
reverse transcribed using Moloney murine leukemia virus (M-ML V) reverse transcriptase 
(Gibco, BRL) and random hexamer primers (Gibco, BRL). The resulting cDNA was PCR 
amplified for 30 cycles (94 ·c, lmin.; 56"C, lmin.; 12·c, lmin. 30sec.) using Fas and FasL 
gene specific primers synthesized from published sequences. The Fas primers were 5' 
GTA CTA ATA GCA TCT CCG AG 3' and 5' CAG GGT GCA GTT TGT TIC CA 3' 
amplifying a 284bp fragment (Watanabe-Fukunaga et al. , 1992). The FasL primers were 
5' ATG CAG CAG CCC ATG A 3' and 5' CTC ACG GAG TTC TGC C 3' amplifying 
a 342bp fragment (Takahashi et al., 1994). As an internal control, primers were designed 
to amplify the (3-actin gene. The P-actin primers were 5' ATG GGT CAG AAG GAC 
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TCC TA 3' and 5' GGT GTA AAA CGC AGC TCA GT 3' (Alonso er al., 1986). 20µL 
of the PCR reaction product was analyzed on a 1.5% agarose gel and visualized by 
ethidium bromide staining. 
Northern Blot Analysis 
Total RNA was prepared from lymph node, spleen, and thymus tissues using guanidine 
isothiocyanate as previously described (Chomczynski and Sacchi, 1987). Ten micrograms 
of total lymph node and splenic RNA and 5µg of total thymic RNA was separated on a 
1.5% denaturing formaldehyde gel and blotted onto a nylon membrane (Duralon-UV 
membrane, Stratagene) using standard procedures (Ausubel et al., 1988). The Fas probe 
was generated by PCR amplification (described above) and labeled with [y-32P]dCTP 
using random hexamer primers. Washing was done to a final stringency of 0.1 x SSCP, 
0. l % SOS at 65°C. Filters were exposed to X-ray film with intensifying screens for 48 
hours at -so·c. 
In Vitro Induction of Apoptosis 
Lymph node cells or thymocytes were cultured at 2xl06 cell/ml in 24-well flat-bottomed 
plates. Cells were cultured in complete medium (RPMI J 640 Complete with 10% fetal 
calf serum) for 16 hours at 37'C in 5% CO/air (Adachi et al., 1995). Cells were 
collected from individual wells and assayed for apoptosis by flow cytometry as described 
below. 
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In Vivo Injection of anti-CD3 Ascites and Staphylococcal Enterotoxin B 
Individual mice were injected intraperitoneally with 200µL of anti-CD3 ascites (50µg or 
1 00µg diluted in PBS) or Staphylococcal Enterotoxin B (SEB) solution (Sigma Chemical ; 
20µg or 50µg diluted in PBS). Control mice were injected with 200µL of PBS only. At 
various times (10, 24, or 48 hours), lymph nodes and thymi were removed and analyzed 
for surface markers and DNA fragmentation by flow cytometry as described below 
(Tucek-Szabo et al., 1996). 
In Vivo Injection of anti-Fas mAbs 
One hundred micrograms of purified anti-Fas mAb (Jo2; Phamingen, San Diego, CA) 
diluted in 200µ1 PBS was injected intraperitoneally into day 18 wild-type and scu,fy mice. 
Thymi and lymph nodes were removed 4.5 hours after injection and assayed for DNA 
fragmentation by gel electrophoresis and flow cytometry as described below (Ogasawara 
el al. , 1995). 
Gel Electrophoresis Analysis of DNA 
The protocol for DNA analysis of apoptotic cells was similar to that previously described 
with modifications (Migliorati et al., 1991 ). Briefly, 4xI 06 cells were dissolved in 1 00µL 
hypotonic lysing buffer ( l00mM NaCl, l0mM Tris, lmM EDTA, 1% SOS, 200ug/ml 
proteinase K, pH 7.5) and incubated 30 minutes to overnight at 37·c. Samples were 
extracted with phenol and chlorofonn (I : 1, v/v) and then with chJorofonn only . 1 00µg/ml 
RNase A was added to each sample, followed by incubation at 37'C for 30 minutes, and 
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phenol/chlorofonn extraction. The DNA was precipitated overnight at -20 'C in 1/10 
volume of 0.3M sodium acetate and 2.5 volumes of 100% ethanol and recovered by 
centrifugation. The DNA pellets were dissolved in TE buffer (l0mM Tris-HCl, pH 8.0, 
and ImM EDTA). 20µL were loaded onto a 2% agarose gel and visualized by ethidium 
bromide staining. 
Quantitation of Apoptosis by Flow CytometJy 
The procedure used to quantify apoptotic cells by flow cytometry was basically as 
described (Telford et al., 1991 ). Briefly, 2x l06 cells were washed in 1ml Hank's balanced 
salt solution (HBSS) and pelleted by centrifugation. The cells were fixed by rapid 
resuspension in 2ml of ice cold 70% ethanol and incubated for a minimum of 30 minutes 
at 4 ·c. Cells were pelleted by centrifugation and resuspended in 1 ml HBSS. After a 20 
minute incubation at 37'C, the cells were washed in 1ml PBS and resuspended in 1ml of 
DNA Staining Reagent (PBS, pH 7.4, containing 0.1% Triton X-100, 0.lmM EDTA, pH 
7.4, 0.05mg/ml RNase A, 50ug/ml propidium iodide). For immediate analysis, the cells 
were stained in DNA Staining Reagent for 1 hour at room temperature or were stored 
overnight in the dark at 4·c for analysis the next day. Cells were analyzed on a F ACScan 
Il flow cytometer (Becton-Dickinson), collecting on FSC log and FL2 linear 1. The 
threshold was set at FL2 of 30 and was set to exclude anything with less fluorescence 
than a chicken red blood cell (CRBC), (Fraker et al. , 1995). At least 10,000 events were 
analyzed for each sample. Apoptotic cells were defined as those cells with less 





Phenotype of Lymphocytes io Scurfy and Wild-type Mice 
The differentiation and activation states of a lymphocyte are critical in determining its 
susceptibil ity to apoptosis. Therefore we examined the phenotypes of the lymphoid cells 
within the scwfy thymus and lymph nodes (inguinal, axillary, and cervical) by flow 
cytometric analysis of cell surface markers. Scuify thymi were smaller in size compared 
to their wild-type littennates, as revealed by a 2-10 fold decrease in the total number of 
cells (Fig. I , A*). Flow cytometric analysis revealed a dramatic decrease in the number 
of CD4+CD8+ double-positive T cells in the scuify thym us (Ave. +/Y = 55.3% ± 18.4%; 
Ave. sf!Y = 9.2% ± 5.2%), with relative increases in the percentages of CD4-CD8-double­
negati ve cells and CD4+CD8- or CD4-CD8+ single-positive cells (Fig. 2, A-B). This 
same thymocyte di stribution is observed in mice treated with glucocorticoids, which 
results in the apoptosis of the CD4+CD8+ double-positive thymocytes (Gruber et al. , 
1994 ). Therefore, rather than an intrinsic defect in thymocyte maturation, the abnormal 
thymocyte distribution observed in scurfy mice is likely to arise from the apoptosis of the 
CD4+CD8+ double-positive population in response to endogenously produced steroids. 
The expression of a number of maturation markers on scwfy and wild-type thymocytes 
were also analyzed (Fig. 3, A-B). Scu,fy thymocytes exhibited staining profiles similar 
• All figures and tables may be found in Appendix A. 
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to wild-type for CD44 and CD25, but had increased percentages of thymocytes expressing 
CD69 (%-CD4+CD69+: Ave. +/Y = 26.6% ± 12.9%; Ave. sf/Y = 69.6% ± 5.3%; %­
CD8+CD69+: Ave. +/Y = 17.1% ± 8.6%; Ave. sf/Y = 49.7% ± 3.8%), (Fig. 3, A-B). 
CD69 is thought to play a role in thymocyte development, and is expressed on 30-60% 
of CD4+CD8- and CD4-CD8+ single-positive thymocytes (Yokoyama et al. , 1988; Swat 
et al., 1993). Therefore the increased expression of CD69 on scu,fy thymocytes is likely 
due to the increased relative percentages of CD4+CD8- and CD4-CD8+ single-positive 
thymocytes in scurfy thymi. However, it cannot be excluded that scurfy CD69-expressing 
thymocytes are activated. Anti-CD3 and PMA have been found to induce CD69 
expression on thymocytes, and signalling through CD69 can induce thymocyte 
proliferation in vitro (Ziegler et al. , 1994; Yokoyama et al., 1988). 
Scurfy lymph nodes were greatly enlarged, and contained 2-4 times more cells than wild­
type controls (Fig. l , B). Within scuify lymph nodes, the relative percentages of T cells 
were significantly decreased (+/Y = 77.3% ± 8.2%; sf/Y = 68.3% ± 4.3%; p<.05) with 
nonnal percentages of B cells (Fig. 4, A). However, because of the increase in absolute 
cell numbers, scurfy lymph nodes contain more absolute numbers of both T and B cells 
than wild-type lymph nodes. Within the T cell subset, scurfy lymph nodes contain 
significantly fewer CD4+ T cells (Ave. +/Y = 54.0% ± 8.6%; Ave. sf/Y = 30.2% ± 
9.7%), with a slight increase in the relative percentage of CDS+ T cells (Fig. 4, B). 
These changes are most dramatically reflected in a decrease in the scurfy CD4/CD8 ratio 
(Ave. +Y = 2.4 ±0.3; Ave. sf/Y = 1.l ± 0.3), (Fig. 4, C). Scurfy lymph node a!P-TcR+ 
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cells were examined for changes in expression of various cell surface markers that are 
used to di stinguish naive T cells from previously activated or memory T cells (Viteua et 
a/. , 1991). Scurfy lymph node T cells were consistently CD44hish, Mel-1410 w, and 
CD45RB10w, a phenotype consistent with previous activation (Fig. 5, A-C). In contrast, 
wild-type lymph node T cells were CD4410w, Mel-14hi, and CD45RBhi, characteristic of 
naive or antigenically inexperienced T cells. (Fig. 5, A-C). These data suggested that a 
significant proportion of scurfy lymph node T cells have been previously activated (Budd 
et al. , 1987; Butterfield et al., 1989; Birkeland et al. , 1989; Jung et al., 1988; Lee et al., 
1990). A percentage of scurfy T cells were also CD69+ and CD25+ (Fig. 5, D-E). CD69 
and CD25 are expressed early and transiently after T cell activation and their expression 
on scurfy T cells suggests that in vivo a majority of scurfy T cell have been recently 
activated (Yokoyama et al., 1989; Sobel and Yokoyama, 1993; Ortega et al. , 1984; 
Moreau et al., 1987). Both scurfy CD4+ and CD8+ T cell subsets contained activated 
cells (Table 1). 
Fas and FasL mRNA Expression 
To determine if scurfy lymphoid cells express Fas mRNA, RT-PCR was performed using 
Fas gene-specific primers on thymus and lymph node derived RNA. Both scwfy and 
wild-type thymi and lymph nodes expressed Fas (Fig. 6). Northern Blot analysis was 
used to quantitate Fas mRNA expression. Scurfy lymph nodes and spleen, but not 
thymus, appear to express higher levels of Fas mRNA than wild-type (Fig. 7). 
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RT-PCR was also performed using FasL gene-specific primers on unstimulated and in 
vitro ConA-activated spleen RNA. Both scu,fy and wild-type activated splenocytes 
expressed FasL (Fig. 8). FasL mRNA was also detected in scu,fy unstimulated spleen 
RNA, suggesting tbat FasL is constitutively expressed in scu,fy spleens, but not wild-type 
spleens (Fig. 8). 
Fas Cell Surface Expression 
Next we examined the cell surface expression of Fas on lymph node cells in scu,fy and 
wild-type mice by flow cytometry . The relative percentages of Fas+a./P-TcR+, 
Fas+CD4+, and Fas+CD8+ T cells ·were similar in scu,fy and wild-type (Fig. 9, B). 
However, scu,fy lymph nodes contained significantly increased percentages ofFas+B220+ 
B cells (Fig. 9, B). All subsets in scu,fy lymph nodes that were examined (a./P-TcR+, 
CD4+, CD8+, B220+) exhibited a significantly increased mean fluorescent intensity (MFI) 
of staining for Fas (Fig. 10, A-D), consistent with their activated phenotype. FasL cell 
surface expression could not be examined because antibodies were not commercially 
available. However, based on constitutive FasL mRNA expression in scu,fy spleens, it 
is expected that the FasL protein would also be constitutively expressed on scu,fy 
lymphoid cells. 
111 Vitro Induction of Apoptosis 
The expression of Fas mRNA and cell surface protein are necessary, but not sufficient, 
to mediate apoptosis. Therefore we examined the ability of scu,fy lymph node cells to 
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undergo apoptosis. Freshly isolated wild-type and scu,fy lymph node cell s showed no 
differences in the percentages of cells undergoing apoptosis ex vivo as measured by flow 
cytometry (Fig. 11, A). However, scu,fy lymph node cells showed significantly increased 
percentages of cell s undergoing apoptosis after 16 hours of culture in complete medium 
compared to wild-type (Ave. +/Y = 34.5% ± 10.7%; Ave. sf/Y = 51.8% ± 8.3%), (Fig. 
11, A). In addition, the percentages of freshly isolated scuify thymocytes undergoing 
apoptosis were significant ly greater than wild-type controls (Ave. +/Y = 0.9% ± 0.5%; 
Ave. sf /Y = 2. 7% ± 2.1 % ), and after 16 hours in culture, an average of 65% of scuify 
thymocytes had undergone apoptosis compared to 40% ofwild-type thymocytes (Fig. 11 , 
B). 
/11 Vivo Induction of Apoptosis by Intraperitoneal Injection of anti-CD3 Ascites, 
Staphylococcal Enterotoxin B (SEB), or anti-Fas mAbs 
Although the above data suggest that scuify thymocytes and lymph node cell s do not have 
an intrinsic defect in the cellular apoptotic machinery, the question of their ability to 
undergo Fas-mediated apoptosis had not been addressed. Therefore, we injected anti-CD3 
and SEB, substances that have been documented to induce apoptosis through a Fas­
mediated mechanism into wild-type and scuify mice (Tucek-Szabo et al., 1996). 
However, inj ection of these compounds at all doses tested was lethal for scuify mutants 
prior to the reported times at which apoptosis can be detected. (Table 2). Injection of 
anti-CD3 and SEB at all doses tested was never lethal for wild-type mice (Table 2). The 
rapid lethality of anti-CD3 and SEB in scuify mice was likely due to toxic shock 
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syndrome (TSS) resulting from the activation of whole T cell subsets leading to massive 
cytokine secretion, multiple organ failure, and death (Chatila et al., 1992). 
We next intraperitoneally injected purified (no sodium azide, low endotoxin) anti-Fas 
mAb (clone Jo2) into scurfy and wild-type mice. 4.5 hours later, lymph nodes and thymi 
were harvested and analyzed for apoptosis by DNA gel electrophoresis (Fig. 12) and 
quantitated by flow cytometry (Fig. 13, A-B). Both wild-type and scurfy thymocytes were 
susceptible to Fas-mediated apoptosis as evidenced by DNA gel electrophoresis and flow 
cytometry (+/Y = 13.43%; sf!Y = 16.49%, 42.33%) Interestingly, a large percentage of 
scurfy lymph node cells, compared to wild-type, were susceptible to Fas-mediated 
apoptosis (+/Y = 5.61 %; sf!Y = 48.03%, 21.90%). 
30 
References 
Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T ., Yoshida, N., and Nagata, 
S. (I995) Targeted mutation in the Fas gene cause hyperplasia in the 
peripheral lymphoid organs and liver. Nature Genetics 11 : 294-300. 
Alonso, S., Minty, A., Bourlet, Y., and Buckingham, M. (1986) Comparison of three 
actin-coding sequences in the mouse: Evolutionary relationships between 
the actin genes of wann-blooded vertebrates. J Mo!. Evol. 23: 11-22. 
Andrews, B.S. , Eisenberg, R.A. , Theofilopoulos, A.N., Izui, S., Wilson, C.B., McConabey, 
P.J., Murphy, E .D., Roths, J.B., and Dixon, F.J. (1978) Spontaneous 
murine lupus-like syndromes. Clinical and immuno-pathological 
manifestations in several strains. J Exp. Med. 148: 1198-1215 . 
Ausubel , F.M., Brent, R., Kingston, R.E., Moore, D.P., Seidman, J.G., Smith, J.A., and 
Struhl , K. (1988) Cummt Protocols in Molecular Biology. (New York, 
New York: John Wiley & Sons). 
Birkeland, M.L., Johnson, P., Trowbridge, l.S., and Pure, E. (1989) Changes in CD45 
isofonn expression accom pany antigen-induced murine T cell activation. 
Proc. Natl. Acad. Sci. USA 86: 6734. 
Budd, R.C., Cerottini, J .C., Horvath, C., Bron, C. , Pedrazzini, T., Howe, R.C., and 
MacDonald, H.R. ( 1987) Distinction of virgin and memory T cells: 
stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic 
stimulation. J lmmunol. 138: 3120. 
Butterfield, K., Fathman, C.G., and Budd, R.C. ( 1989) A subset of memory CD4+ 
helper T lymphocytes identified by expression of pgp-1 . J. Exp. Med. J69: 
1461 . 
Cascino, I. , Fiucci, G., Papoff, G., and Ruberti, G . ( 1995) Three functional soluble 
forms of the human apoptosis-inducing Fas molecule are produced by 
alternative splicing. J Immunol. 154: 2706-2713. 
Chatila, T., Scholl, P., Ramesh, N., Trede, N., Fuleihan, R ., Mario, T., and Geha, R.S. 
(1992) Cellular and molecular mechanisms of immune activation by 
microbial superantigens: studies using toxic shock syndrome toxin. Chem. 
Immunol. 55: 146. 
Chinnaiyan, A.M., O'Rourke, K., Tewari, M ., and Dixit, V.M. (1995) FADD, a novel 
death domain-containing protein, interacts with the death domain of fas and 
31 
initiates apoptosis. Cell 81 : 505-512. 
Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chlorofonn-extraction. A nalyt. Biochem . 
162: 156-1 59. 
Chu, J., Drappa, J., Parnassa, A., and Elkon, K.B. (1993) The defect in Fas mRNA 
expression in 'MR.LI/pr mice is associated with insertion of the 
retrotransposon, ETn. J Exp. Med. 178: 723-730. 
Cohen, P.L., and Eisenberg, R.A. (199 1) Lpr and gld: Single gene models of systemic 
autoimmunity and lymphoproliferative disease . A nnu.Rev. lmmunol. 9: 
243-69. 
Darzynkiewicz, Z., Bruno, S. , Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P. and 
Traganos, F. (1992) Features of apoptotic cells measured by flow 
cytometry. Cytomet,y 13: 795-808. 
Darzynkiewicz, Z. , Li, X., and Gong, J. (1994) Assays of cell viability: Discrimination 
of cell s dying by apoptosis. Meth. Cell. Bio. 41 : 15-38. 
Dhein, J., Daniel, P.T., Trauth, B.C., Oehm, A., Moeller, P., and Krammer, P.H. ( 1992) 
Induction of apoptosis by monoclonal anitbody anti-APO class switch 
variants is dependent on cross-linking of APO- I cell surface antigens. J 
lmmunol. 149: 3166. 
Godfrey, V.L. , Wilkinson, J.E., and Russell, L.B. (199 1) X-linked lymphoreticular 
di sease in the scurfy (sf) mutant mouse. Am. J Pathol. 138: 1379-1386. 
Gruber, J., Sgonc, R., Hu, Y.H., Beug, H., and Wick, G. (1994) Thymocyte apoptosis 
induced by elevated endogenous corticosterone levels. Eur. J lmmunol. 
24: 1115-1121. 
Herron, L.R., Eisenberg, R.A., Roper, E., Kakkanaiab, V.N., Cohen, P .L., and Kotzin, 
B.L. ( 1993) Selection of the T cell receptor repertoire in !pr mice. J 
Immunol. 151: 3450-3459. 
Hughes, D.P.M., and Crispe, I.N. (I 995) A naturally occurring soluble isofonn of 
murine Fas generated by alternative splicing. J. Exp. Med. 182: 1395-
1401. 
lzui, S. , Kelley, V.E., Masuda, K., Yoshida, H., Roths, J.B., ans Murphy, E.D. ( 1984) 
Induction of various autoantibodies by mutant gene lpr in several strains 
32 
of mice. J. lmmunol. 133: 227-233. 
Jones, L.A. , Chin, L.T., Longo, D.L., and Kruisbeek, A .M. (1990) Peripheral clonal 
elimination of functional T cells. Science 250: 1726. 
Jung, T.M., Gallatin, W .M ., Weissman, I.L., and Dailey, M.O. (1988) Down regulation 
of homing receptors after T cell activation . .J. lmmunol. 141: 4110. 
Kabelitz, D., Pohl, T ., and Pechhold, K. (1993) Activation-induced cell death (apoptosis) 
of mature peripheral T lymphocytes. Jmmunol. Today 14: 338-339. 
Krammer, P.H., Dhein, J., Walczak, H., Behrmann, I ., Mariani, S., Matiba, B., Fath, M ., 
Daniel, P.T., Knipping, E., Westendorp, M.O., Stricker, K., Baumler, C., 
Hellbardt, S., Genner, M., Peter, M.E., and Debatin, K . (1994) The role 
of APO-I-mediated apoptosis in the immune system. lmmun. Rev. 142: 
175-191. 
Lee, W.T., Yin, X .M., and Vitetta, E.S. (1990) Functional and ontogenetic analysis 
murine CD45R11; and CD45RB1° CD4+ T cells. J. lmmuno/. 144: 3288. 
Lennon, S.V., Martin, S.J., and Cotter, T.G. (1991) Dose-dependent induction of 
apoptosis in human tumour cell lines by widely diverging stimuli . Cell. 
Pro/if. 24: 203-2 14. 
Lynch, D.R ., Ramsdell, F., and Alderson, M.R. ( 1995) Fas and FasL in the homeostatic 
regulation of immune responses. lmmunol. Today 16: 569-573. 
Migliorati, I.N., Pagliacci, M .C., Grignani, F., and Riccardi , C . (199 1) A rapid and 
simple method for measuring thymocyte apoptosis by propidium iodide 
staining and flow cytometry. J. lmmunol. Meth. 139: 271-279. 
Moreau, J.L., Nabholz, M., Diamantstein, T., Malek, T., Shevach, E., and Theze, J . 
(I 987) Monoclonal antibodies identify three epitope clusters on the mouse 
p55 subunit of the interleukin 2 receptor: relationship to the interleukin 
2-binding site. Eur. J. lmmunol. 17: 929-935. 
Nishimura, Y., Ishii, A., Kobayashi, Y., and Yonehara, D. (1995) Expression and 
function of mouse Fas antigen on immature and mature T cells. J. 
lmmunol. 154: 4395-4403. 
Nossal, G.J.V. ( 1994) Negative selection of lymphocytes. Cell 76: 229-240. 
Ogasawara, J., Suda, T, and Nagata, S. (1995) Selective apoptosis of CD4+CD8+ 
thymocytes by the anti-Fas antibody. J Exp. Med. 181: 485-491. 
33 
Ortega, R.G., Robb, R.J. , Shevach, E.M., and Malek, T.R. (1984) The murine IL-2 
receptor I. Monoclonal antibodies that define distinct functional region 
on activated T cells and react with activated B cells. J lmmuno/. 151: 
4431-4444. 
Osborne, B.A. (1 996) Apoptosis and the maintenance of homeostasis in the immune 
system. Curr. Opin. lmmunol. 8: 245-254. 
Russell , J.H., White, C.L., Loh, D.Y., and Meleedy-Rey, P. (1991 ) Receptor-stimulated 
death pathway is opened in mature T cells. Proc. Natl. Acad. Sci. USA 
88: 2151. 
Russell , J.H., Rush, B., Weaver, C., and Wang, R. ( 1993) Mature T cells of autoimmune 
lprllpr mice have a defect in antigen-stimulated suicide. Proc. Natl. A cad. 
Sci. USA 90: 4409-4413. 
Schwartz, L.M. and Osborne, B.A. (I 993) Programmed cell death, apoptosis, and killer 
genes. lmmunol. Today 14: 582-590. 
Singer, G.G., and Abbas, A.K. (1994) The Fas antigen is involved in peripheral but not 
thymic deletion of T lymphocytes in T cell receptor transgenic mice. 
Immunity }: 365-371. 
Sobel, E., and Yokoyama, W. (1993) Aberrrant expression of the Very Early Activation 
antigen on MRL/MP-lpr/lpr lymphocytes. 150: 673-682. 
Stanger, B.Z., Leder, P., Lee, T.H., Kim, E., and Seed, B . (1995) RlP: a novel protein 
containing a death domaim that interacts with Fas/APO-1 (CD95) in yeast 
and causes cell death. Cell 81 : 513-523. 
Suda, T., Takahashi, T., Golstein, P. and Nagata, S. (1993) Molecular cloning and 
expression of the Fas ligand, a novel member of the tumor necrosis factor 
fami ly. Cell 75: 1169. 
Suda, T. , Okazaki, T., Naito, Y., Arai, N., Ozaki, S., Nakao, K., and Nagata, S. (1995) 
Expression of the Fas ligand in cells of the T cell lineage. J lmmunol. 
154: 3806-3813. 
Surh, C.D. and Sprent, J. (1994) T-cell apoptosis detected in situ during positive and 
negative selection in the thymus. Nature 372: 100-103. 
Swat, W., Dessing, M., von Boehmer, H., and Kisielow, P. (1993) CD69 expression 
during thymic selection anda maturation of CD4+8+ thymocytes. E ur. J. 
Immunol. 23: 739-746. 
34 
Takahashi, T., Tamaka, M., Brannan, C.I ., Jenkins, N .A ., Copeland, N.G., Suda, T. and 
Nagata, S. (1994) Generalized lympboproliferative disease in mice caused 
by a point mutation in the Fas ligand. Cell 76: 969-976. 
Tanaka, M., Suda, T., Takahashi, T., and Nagata, S. (1995) Expression of the functional 
soluble fonn of human Fas ligand in activated lymphocytes. EMBOJ 14: 
1129-1135. 
Tartaglia, L.A ., Ayres, T.M., Wong, G.H.W., and Goedde), D .V. (1993) A novel domain 
within the 55 kd TNF receptor signals cell death. Cell 74: 845. 
Telford, W .G., King, L.E.,and Fraker, P .J. (1991) Evaluation of glucocortcoid-induced 
DNA fragmentation in mouse thymocytes by flow cytometry. Cell Pro/if 
24: 447-459. 
Tucek-Szabo, C.L., Andjelic, S., Lacy, E., Elkan, K.B., and Nikolic-Zugic, J. (1996) 
Surface T cell Fas receptor/CD95 regulation, in vivo activation, and 
apoptosis. J Immunol. 156: 192-200. 
Van Parijs, L., Ibraghimov, A., and Abbas, A .K . (I 996) The roles of costimulation and 
Fas in T cell apoptosis and peripheral tolerance. Immunity 4: 321-328. 
Vitetta, E.S., Berton, M.T., Berger, C., Kepron, M ., Lee, W.T., and Yin, X.M . (L99 1) 
Memory B and T cell s. Annu. Rev. lmmunol. 9: 193. 
Von Boehmer, H. ( 1994) Positive selection of lymphocytes. Cell 76: 2 19-228. 
Watanabe-Fukunaga, R., Brannan, CJ., Itoh, N., Yonehara, S., Copeland, N.G., Jenkins, 
N.A. and Nagata, S. (1992) The cDNA structure, expression and 
chromosomal assignment of the mouse Fas antigen . J Jmmunol. 148: 
1274-1279. 
Wofsy, D ., Hardy, R.R., and Seaman, W .E. (1984) The proliferating cells in auto­
immune MRL/lpr mice lack L3T4, an antigen of "helper" T cells that is 
involved in the response to class 11 major histocompatability antigens. 
J. Tmmunol. 136: 2686-2689. 
Wyllie, A.H., Morris, R.G. , Smith, A.L., and Dunlop, D. ( 1984) Chromatin cleavage in 
apoptosis: Association with condensed chromatin morphology and 
dependence on macromolecular synthesis. J Pathol. 142: 67-77. 
Yokoyama, W .M ., Koning, F., Kehn, P.J., Pereira, G.M.B ., Sting!, G., Coligan, J.E., and 
Shevacb, E.M. (1988) Characterization of a cell surface-expressed 
35 
disulfide-linked dimer involved in murine T cell activation. J. lmmunol. 
141 : 369-376. 
Ziegler, S.F., Ramsdell, F., and Alderson, M.R. (1994) The activation antigen CD69. 
Stem Cells 12: 456-465. 
36 
Appendix Apoptosis 
Figure 1. Absolute cell numbers in lymphoid organs. Single-cell suspensions were 
prepared and quantified from thymi and lymph nodes (cervical, inguinal, axillary) as 
described in Material and Methods. (A) Scurfy thymi contained 2-9 times fewer cells 
compared to age-matched wild-type thymi . (B) Scurfy lymph nodes contained 2-4 times 
more cells than age-matched wild-type littermates. Data represent the mean and standard 
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Figure 2. Flow cytometric analysis of thymocyte subsets. Thymocytes from day 18 wild­
type (A) and scurfy (B) mice were stained for flow cytometric analysis as described in 
Materials and Methods. Dead cells and debris were eliminated on the basis of forward 
and side light scatter during analysis. Numbers are representative of the percentages of 




















Figure 3. Flow cytometri c analysis of thymocyte maturation markers. Thymocytes from 
day 18 wild-type and scwfy mice were stained for flow cytometric anaJysis as described 
in Materials and Methods. Thymocytes were gated on CD4+ or CD8+ T cells and dead 
cells and debris were eliminated on the basis of forward and side light scatter. (A) The 
percentage of C04+ thymocytes that are CD69+ or CD44+ or CD25+. (B) The 
percentage of C08+ thymocytes that are CD69+ or CD44+ or CD25+. Data represent the 






















Figure 4. Flow cytometric analysis of lymph node subsets. Lymph node cells isolated 
from wild-type and scwfy mice (age 15-21 days) were stained for flow cytometric 
analysis as described in Materials and Methods. Dead cells and debris were eliminated 
on the basis of forward and side light scatter during analysis. (A) The percentages of 
cx.lP-TcR+ T cells and B220+ B cells; (B) the percentages of CD4+ and CD8+ T cells; 
(C) the CD4/CD8 ratio in the lymph nodes. Data represent the mean and standard error 



























Figure S. Altered expression of activation markers on scwfy lymph node T ce1ls. Lymph 
node cells isolated from day 18 wild-type and scurfy mice were stained for flow 
cytometric analysis as described in Materials and Methods. Dead cells and debris were 
eliminated on the basis of forward and side light scatter during data analysis. The 
histograms represent the percentage of live a!P-TcR+ T cells that are (A) CD44hish; (B) 
Mel- 14high (C) CD45RBhish; (D) CD25+; and (E) CD69+. Data are representative of four 
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Figure 6. RT-PCR analysis of Fas mRNA expression. RNA isolated from day 24 wild­
type and scu,fy mice was subjected to RT-PCR for Fas mRNA expression as described 
in Material s and Methods. A 284 basepair (bp) Fas band was amplified in lanes 2 (wild­
type thymus), lane 4 (scu,fy thymus), lane 7 (wild-type lymph node), and lane 9 (scu,fy 
lym ph node). Lanes 3, 5, 8, and 10 are negative control reactions (Rr reactions). Lanes 
l and 6 are molecular weight standards (<l>x174/Haelll). 
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Figure 7. Nothem blot analysis of Fas mRNA expression. Total RNA was isolated from 
day 24 wild-type and scurfy lymphoid organs. (A) The blot was probed with a 
radiaolabeled PCR-generated fas probe as described in Materials and Methods. (8 ) The 
etbidium bromide stained formaldehyde gel was used to standardize loading. Lanes 1, 
4, 7 correspond to wild-type lymph node, spleen, and thymus RNA respectively . Lanes 
2, 5, 8 correspond to scurfy Jymph node, spleen, and thymus RNA respectively. Lanes 
3, 6, 9 correspond to /pr/lpr lymph node, spleen, and thymus RNA respectively. The Fas 
mRNA corresponds to a 2 . I kilobase (kb) transcript (Watanabe-Fukunaga et al., 1992). 
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Figure 8. RT-PCR analysis of Fasl mRNA expression. RNA was extracted from day 
24 wild-type and scurfy unstim ulated spleens and day 17 ConA-activated splenocytes and 
subjected to R T-PCR for FasL mRNA expression as described in Materials and Methods. 
A 340 bp fragment was amplified in lane 7 (wild-type activated spleen), lane 10 (scwfy 
unstim ulated spleen), and lane 12 (scurfy activated spleen). Lanes 3, 5, 8, 11 , and 13 are 
negative control reactions (Rr reactions). Lane 4 is a /J-actin positive control reaction 
for wild-type unstimulated spleen and amplified a I kb fragment. Lanes 1, 6, and 9 are 
molecular weight standards (<I>xl 14/HaellI). 
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Figure 9. Flow cytometric analysis of Fas cell surface expression. Lymph node cells 
were stained for cell surface expression of Fas by flow cytometric analysis as described 
in Methods and Materials. (A) The percentage of Fas+ cells in wild-type and scurfy 
lymph nodes; (B) the percentage of CD4+Fas+, CD8+Fas+, and B220+Fas+ cells in 
lymph nodes. Live cells were discriminated by forward and side light scatter and gated 
on CD4+, CD8+ or B220+ cells. Data represent the mean and standard error of the mean 
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Figure 10. Mean fluorescent intensity of Fas cell surface expression. Lymph node cells 
were stained and analyzed as described in Figure 9. The mean fluorescent intensity (MFJ) 
of (A) Fas+ only lymph node cells; (B) CD4+Fas+ T cell s; (C) CD8+Fas+ T cells; and 
(D) B220+Fas+ B cells. Data represent the results of 4-7 independent experiments. The 
ages of the mice range from 18-2 I days. 
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Figure 11. Spontaneous apoptosis oflymphocytes ex vivo and in vitro. Wild-type, scurfy, 
and lpr/lpr lymph node cells (A} and thymocytes (B) were removed and examined for ex vivo 
apoptosis (fresh) by flow cytometry. In addition, lymph node cells and thymocytes were 
cultured in RPMI 1640 Complete medium ( 10% FCS) as described in Materials and Methods. 
Lprl lpr thymocytes and lymph node cells represent Fasnegative controls. The percentage of 
cells undergoing apoptosis (% Ao) at 16 hours was quantitated by flow cytometry. Data 
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Figure 12. In vivo induction of Fas-mediated apoptosis. One hundred micrograms of 
purified anti-Fas mAb (clone Jo2) was injected into day 19 wild-type and scurfy mice. 
Lymph nodes, spleen, and thymus were removed 4.5 hours later and analyzed for DNA 
fragmentation by gel electrophoresis as described in Materials and Methods. DNA 
isolated from untreated wild-type and scurfy lym ph nodes and thymus are represented in 
lanes 4, 6, 9, and 11 respectively. Lanes 5 (lymph nodes) and 10 (thymus) represent 
DNA isolated from wild-type mice 4.5 hours after injection with l00ug anti-Fas mAb. 
Lanes 7 and 8 (lymph nodes) and lanes 12 and 13 (thymus) represent DNA isolated from 
scurfy mice injected with 1 00ug anti-Fas mAbs. Lane 3 is a 1 00bp DNA marker and lane 
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Figure 13. Quantitation by flow cytometry of apoptosis induced by injection of anti-Fas 
mAb. Anti-Fas mAb were injected as described in Figure 12. Staining of lymph node 
cells and thymocytes for flow cytometry were performed as described in Materials and 
Methods. Ml represents the subgenomic or apoptotic region of cells. The percentages 
represent the percent of cells that are in region Ml. (A) represents the percentage of 
lymph node cells undergoing apoptosis and (B) represents the percentage of thymocytes 
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Table 1: Activation marl<e~ on scurfy CD4+ and CD8+ lymph node T cell subsets 
% CD45RB+ Lo Cells% CD44+ HI Cell s % CD69• Cells 
Mice No. 
CD8b co4• CD8b CD4° CD8b CD4° 
+/Y (1) 5.7 11.5 2 .6 5.9 8.2 2 .4 
sf/Y (3) 71 .6 ± 9.4 39.5 ± 1.5 16.5±3.2 16.0 ± 1.0 50.6 ± 2.9 5.1 ± 1.0 
°' °' 0 The percentage of CD4+ T cells from the lymph nodes of wild-type and scwfy mice which express CD44, CD4SRB, and 
MEL-14 as analyzed by flow cytometry. Data represent the mean and standard error of the mean. 
bThe percentage of CD8+ T cells from the lymph nodes of wild-type and scwfy mice which express CD44, CD45RB, and 
MEL-14 as analyzed by flow cytometry. Data represent the mean and standard error of the mean. 
Table 2: Intraperitoneal injection of anti-CDJ ascites or Staphyloccocal eoterotoxin 
B 
age injectiona dose hours mortality 
(days) ( dead/total) 
+IY (14; 21) anti-CD3 I00µg 48 0/3 
sfspf/ Y (14) anti-CD3 l00µg 48 2/2 
sf/Y (21) anti-CD3 lO0µg 48 1/1 
+IY (12; 13) anti-CD3 I 00µg 8-10 0/2 
+/Y (12; 13) PBS 8-10 0/2 
sf spf/Y (12; 13) anti-CD3 l00µg 8-10 2/2 
sf spf/Y (12; 13) PBS 8-10 0/2 
+IY (13) anti-CD3 50µg 48 0/1 
+/Y (13) PBS 48 0/1 
sf spf/Y (13) anti-CD3 50µg 48 2/2 
sfspf/Y (13) PBS 48 0/1 
+/Y (11) anti-CD3 50µg 24 0/1 
+/Y (11) PBS 24 0/1 
sf spf/Y (11) anti-CD3 50µg 24 1/1 
sf spf/Y (11) PBS 24 0/1 
+IY (20) SEB 50µg 48 0/1 
sf/Y (20) SEB 50µg 48 2/2 
+/Y (24) SEB 20µg 24 OIi 
sf/Y (24) SEB 20µg 24 0/1 
Summary: anti-CD3 SEB PBS 
(mortality) 
+/Y 0/7 0/2 0/4 
sf spf/Y 7/7 ndb 0/4 
sf/Y 1/1 2/3 ndb 
" Wild-type and scurfy or scurfy sparse-fur mice were injected intraperitoneally with 
various concentrations of anti-CD3 ascites (IO0µg, 50µg) and SEB (50µg, 20µg) diluted 
in 200µL PBS or PBS only. 
b Not done. 
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Part 3 
Expression of Elements of the CD28/CTLA-4/B7 Pathway 




The Two Signal Model of T CeU Activation 
The generation of an optimal immune response requires antigen-specific activation and 
clonal expansion of T cells into effector cells. The activation phase of this process 
requires two distinct signals. The first signal is mediated by ligation of the T cell 
receptor by antigen complexed to MHC molecules. The second, costimulatory signal is 
provided by ligands present on 'professional ' antigen presenting cells (APC's) and is 
antigen-independent (Schwartz, 1990). Both signals are required for T cell activation, 
clonal expansion, and differentiation into effector cells. Antigenic stimulation in the 
absence of a costimulatory signal results in a functionally unresponsive state referred to 
as anergy (Harding et al., 1992). 
The B7-1/B7-2:CD28/CTLA-4 Costimulatory Pathway 
The most well-documented costimulatory pathway involved in T cell activation is the B7-
l /B7-2:CD28/cytotoxic T lymphocyte-associated molecule-4 (CTLA-4) pathway (Norton 
et al. , 1992). This signall ing pathway is extremely complicated as there are two T cell 
surface receptors and at least two ligands. Both receptors and ligands exhibit complex 
patterns of expression and there is evidence that the functional outcome of TcR ligation 
involves an integration ofpositive and negative signals from the TcR, CD28, and CTLA-4 
(Chambers et al., 1996). 
69 
CD28 and CTLA-4 T CeJI Surface Receptors 
CD28 and CTLA-4 are cell surface receptors belonging to the immunoglobulin 
superfamily (Gross et al., 1990; Freeman et al., 1992). It is thought that they arose by 
gene duplication as the cd28 and ctla-4 genes are linked on chromosome 2 in humans and 
chromosome 1 in mice and the protein receptors share a nucleotide sequence homology 
of about 75% (Dariavich et al., 1988; Howard et al., 1991 ). CD28 is constitutively 
expressed on virtually all murine T cells, and is upregulated upon activation (Gross et al., 
1992). The expression pattern of CTLA-4 is more complex. Ctla-4 mRNA is not 
detectable in unstimulated T cells by Northern Blot analysis, but is readily detectable in 
activated T cells. Despite abundant mRNA expression, CTLA-4 cell surface expression 
on activated T cells is difficult to detect by flow cytometry, only reaching levels that are 
3% of that observed for CD28 (Linsley et al., 1992). Maximum CTLA-4 surface 
expression peaks between 24-48 hours after stimulation, with murine CD8+ T cells 
demonstrating higher levels than CD4+ T cells (Freeman et al., 1992; Lindsten et al., 
I993; Linsley et al., 1992). ln 1995, it was shown that CTLA-4 contains an intracellular 
localization motif in its cytoplasmic tail which localizes the protein to the perinuclear 
Golgi and post-Golgi compartments (Leung et al., 1995). Therefore, although CTLA-4 
functions at the cell surface, it is mainly located intracellularly and continuously cycles 
to the surface (Linsley et al., 1996). 
The B7 Ligands 
The CD28 and CTLA-4 receptors bind the same ligands, BB1/B7-l (CD80) and B7-2 
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(CD86) expressed on APC's. Although CTLA-4 surface expression is minimal, it is the 
high avidity receptor for the B7 ligands, binding both B7-l and B7-2 with a 20-50 times 
higher affinity than CD28 (Linsley et al., 1991; Linsley et al., 1994). The B7-1 
glycoprotein was originally described as a B cell activation marker and its expression is 
restricted to 'professional' APC's such as activated B cells, dendritic cells, macrophages, 
and activated T cells (Larsen et al., 1992; Azuma et al., 1993; Hathcock et al., 1994; 
Prabhu Das et al. , 1995). B7-2 is also expressed by 'professional' APC's, however, low 
levels of B7-2 have been detected on resting B cells as well. Both B7-l and B7-2 
expression are upregulated upon B cell activation (Freeman et al., 1991; Lenschow el al. , 
1993; Hathcock et al. , 1994). In addition, it was recently found that freshly isolated 
murine T cells express low levels of B7-2, but not B7-1, and both are upregulated upon 
T cell activation (Hathcock et al., 1994; Inaba et al. , 1994). In addition to Band T cell 
activation, B7 expression is induced by signalling through the CD40/CD40L pathway, and 
influenced by a number of cytokines (Lenschow et al., 1996a). The B7 ligands also 
exhibit differences in the kinetics of their expression. Regardless of the type of APC, B7-
2 is expressed within 6 hours of stimulation, where as B7-l is not detectable until 18-24 
hours after stimulation (Lenschow et al. , 1993 ; Hathcock et al., 1994). This led to the 
hypothesis that B 7-1 was involved in the initiation of T cell responses, while B7-2 was 
important in sustaining the response (Boussiotis et al., 1996). However, the functional 
outcome of differential B7 signaling appears more complicated than this, and some groups 
have suggested that these molecules can influence Th l/Th2 subset differentiation 
(Kuchroo et al., 1995; Lenschow et al., 1995a; Lenschow et al., 1995b; Lenschow et al., 
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1996b). Whether B7-1 and B7-2 induce distinct signalling pathways resulting in distinct 
functional outcomes is still unresolved. 
CD28 Signalling 
It has long been established that signaling through CD28 in conjunction with ligation of 
the TcR, provides a 'second' signal that is necessary for optimal T cell clonal expansion 
and differentiation into effector cells. CD28 signalling can prevent anergy largely in part 
because of its role in the initiation of transcription and stabilization of a number of 
cytokine mRNAs. Particularly important in preventing T cell anergy is CD28-dependent 
production of IL-2 and up-regulation of the IL-2R a , f3, and y chains (Lindsten et al., 
1989; Cerdan et al. , 1992). In vitro anergy caused by inadequate costimulation can be 
reversed by addition of exogenous IL-2 or other cytokines which signal through the 
common gamma chain of the IL-2R (Boussiotis et al., 1994 ). Although the molecular 
basis for cytokine mRNA stabilization is not clear, it has been hypothesized that CD28 
signalling interferes with the rapid turnover of cytokine mRNA's containing AU-rich 
instability sequences in their 3' untranslated regions (Schwartz, 1992). 
More recent data in CD28 immunobiology has suggested that a primary function ofCD28 
may be to prevent apoptosis and enhance cell survival. Following TcR ligation and CD28 
costimulation, the level of the cell survival protein, bcl-xl, increases on T cells (Chao et 
al., 1995) Bel-xi can heterodimerize with bax, and together they protect T cells from Fas­
mediated apoptosis. The level of bcl-xl expression on T cells has been positively 
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correlated with resistance to Fas-mediated apoptosis (Boise et al., 1995). 
CTLA-4 Signalling 
In contrast to the well documented role of CD28 in the costimulation of T cells, the role 
of CTLA-4 has long been controversial. Because of its homology to CD28 and the fact 
that it also binds the B7 ligands, with a higher affinity than CD28, it was hypothesized 
to play a similar, possibly synergistic role with CD28 in augmenting T cell proliferation 
in response to TcR ligation (Linsley et al., 1991). Initial in vitro experiments supported 
this hypothesis as anti-CTLA-4 mAbs added to cultures stimulated with anti-CD3 mAb 
and anti-CD28 mAb resulted in an increase in T cell proliferation over cultures stimulated 
with anti-CD3 and anti-CD28 mAbs alone (Linsley et al., 1992). However, further 
experiments using a CTLA-4-lg fusion protein, consisting of the extracellular domain of 
CTLA-4 and the Fe portion of immunoglobulin G, and Fab fragments of the anti-CTLA-4 
mAB suggested that blocking B7 interactions with CTLA-4 was not in fact sending a 
positive signal, but enhanced proliferation was a result of blocking a negative signal 
(Walunas et al. , 1994). In addition, crosslinking of CTLA-4 inhibited proliferation and 
IL-2 secretion by T cells stimulated with anti-CD3 and anti-CD28 mAbs (Krummel and 
Allison, 1995; Krummel and Allison, 1996). Although the in vitro data supported an 
inhibitory signalling role for CTLA-4 in T cell activation, it wasn't until 1995 when 
Waterhouse et al. created mice with a null mutation in CTLA-4 (CTLA-4 _,_ ) that a 
definitive role for CTLA-4 as a negative regulator of T cell activation was established 
(Waterhouse et al. , 1995). 
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CTLA-4.J. Mice 
Mice carrying a null mutation in CTLA-4 exhibit a massive lymphoproliferative disorder 
culminating in death at 2-3 weeks of age. The CTLA-4-1. phenotype is characterized by 
the accumulation of activated T and B cells in the peripheral lymphoid organs of mutant 
mice and considerable infiltration of T cells into non-lymphoid organs mediating lethal 
tissue damage. Analysis of mutant thymi revealed increased proportions of CD4+ and 
CDS+ single-positive T cells, and a reduction in CD4+CD8+ double-positive T cells, 
resulting in a smaller thymus. Analysis of thymic maturation markers CDS, CD69, and 
CD44 suggested that thymic maturation was intact in CTLA-4-/- mutants, and that the 
single-positive thymocytes were not activated. T cells isolated from the peripheral 
lymphoid organs of CTLA-4-/- mutants showed expression patterns characteristic of 
previously activated T cells. Analysis of the relative percentages of various TcR VP 
elements indicated that the expansion of activated T cells in CTLA-4-/- mice was 
polyclonal in nature. In support of their in vivo activated phenotype, CTLA-4-/- T cells 
spontaneously proliferate in culture, and show increased proliferative responses compared 
to wild-type in response to stimulation through the TcR. These results suggest that in the 
absence of CTLA-4, T cells are activated, although the nature of the activating stimulus 
has not been resolved. A defect in apoptosis could also result in the accumulation of 
activated T cells in the periphery of CTLA-4-/- mice. However, crosslinking of Fas in 
both wild-type and mutant T cells resulted in comparable levels of apoptosis. Based on 
this data, CTLA-4 has been suggested to be a negative regulator of T cell activation, and 
its absence results in dysregulated peripheral lymphocyte homeostasis (Waterhouse et al., 
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1995; Tivol et al., 1995). 
Recent experiments to detennine how CTLA-4 functions to negatively regulate T cell 
activation suggest that CTLA-4 inhibits T cell activation by blocking TcR/CD28-mediated 
lL-2 production and IL-2R expression, as well as upregulation of the T cell activation 
marker, CD69 (Krummel and Allison, 1996). Although it was reported that activated 
human T cells cultured in the presence of anti-CTLA-4 mAbs resulted in apoptosis, more 
recent reports suggest that CTLA-4 functions to down-regulate T cell activation in the 
absence of apoptosis (Gribben et al. , 1995; Krummel and Allison, 1996; Walunas et al., 
1996). This inhibition of T cell activation by CTLA-4 is accomplished by blocking T 
cell progression from the G1 to the S phase of the cell cycle and is most pronounced 72 
hours after initial T cell activation (Krummel and Allison, 1996; Walunas et al. , 1996). 
Although apoptosis has long been recognized as the primary mechanism for maintaining 
both central and peripheral immune tolerance, the severe phenotype of CTLA-4 knockout 
mice suggests that other down-regulatory mechanisms may play an even more important 
role. Mice with defects in the Fas/FasL pathway, thought to be the main apoptotic 
pathway involved in peripheral tolerance, demonstrate progressive lymphadeoopathy and 
autoimmunity which is generally not lethal until 6-8 months of age (Chu et al., 1993; 
Takahashi et al., 1994). Tn contrast, mice lacking CTLA-4 exhibit massive 
lympboproliferation and autoimmune-like tissue damage that is lethal by 3-4 weeks ofage 
(Waterhouse et al., 1995; Tivol et al., 1995). Taken together, this implies that 
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CD28/CTLA-4/B7 interactions may play a more significant role in the maintenance of 
peripheral lymphocyte homeostasis than Fas/FasL-mediated apoptosis. 
Although the signalling pathways involved in CD28/CTLA-4/B7 signalling are complex 
and not fully understood, most evidence suggests that T cell activation involves the 
integration of positive signals mediated through the TcR and CD28, and negative signals 
transmitted through CTLA-4 (Chambers et al. , 1996). In fact, experiments involving 
CD28-deficient mice have implied that although CD28 is not necessary for CTLA-4 
expression, CD28 signalling enhances CTLA-4 surface expression (Walunas et al., 1994). 
Maybe most importantly, this pathway offers new therapeutic approaches to 
transplantation, tumor immunity, and autoimmune disease. A number of experiments in 
which tumor cells were transfected with B7-1 or B7-2, resulted in potent and enhanced 
anti-tumor responses (Ramarathinam et al., 1994; Townsend and Allison, 1993; Townsend 
et al., 1994). In addition, blocking B7-signalling with CTLA-4Ig has extended, and in 
some cases prevented, transplant rejection in mice (Lenschow et al., 1992). Lastly, 
CTLA-4Jg treatment has been demonstrated to significantly inhibit the onset of diabetes 
in the non-obese diabetic (NOD) autoimmune mouse model (Lenschow et al., 1995a). 
Research Goals 
Scurfy mice exhibit a rapidly fatal lymphoproliferarive disease with many pbenotypic 
similarities to homozygous CTLA-4 knockout mice. Because ctla-4 is an autosomal gene, 
76 
and scu,fy is X-linked, they are definitely not the same gene. However, the phenotypic 
similarities between the two mutant mice suggests that they may involve overlapping 
signalling pathways. Therefore, the goal of this research was to examine the expression 
of Ctla-4 mRNA and CTLA-4 protein expression in the scurfy mouse in an attempt to 
detennine if the scurfy phenotype results from misexpression of CTLA-4. 
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Chapter 2 
Methods and Materials 
Mice 
The scurfy mouse stocks were previously descibed (Part 2, Methods and Materials, pg. 
19). All mice were used between 18 and 2 1 days of age. 
Cell Preparations 
Cell suspensions were prepared from lymph nodes (axillary, inguinal, and cervical) as 
previously described (Part 2, Methods and Materials, pg. 19) 
Antibodies 
All antibodies were purchased from Phanningen (San Diego, CA). Non-specific binding 
of immunoglobulins was blocked by addition of CD16/CD32 (Fe gamma Ill/II Receptor) 
Fe Block to all cells to be stained for flow cytometric analysis. Lymph node cells were 
stained with directly-conjugated primary antibodies to a'3-TcR, CD4, CD8, B220, TNP, 
CTLA-4, B7-1 , B7-2, and CD28. Streptavidin-phycoerthyrin was used as a secondary 
antibody to label the biotinylated anti-CD28 mAb. A hamster anti-TNP-PE IgG isotype 
control (Pharmingen, San Diego, CA) was used to subtract out background staining in all 
CTLA-4 samples. 
Flow Cytometric Analysis 
The procedure for surface staining of cells with mAbs for flow cytometric analysis was 
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described previously (Part 2, Methods and Materials, pg. 20). Twenty thousand events 
were collected for all CTLA-4 samples, and ten thousand events were collected for all 
other samples. Dead cells and debris were eliminated based on forward and side light 
scatter patterns during analysis. 
Intr.icellular CTLA-4 Staining 
The procedure used to stain cells for intracellular CTLA-4 expression was a modification 
of (Sander et al., 1991; Prussin and Metcalfe, 1995). One million lymph node cells were 
suspended in 50µL of Staining Buffer (1 ml FCS, 0.1 g sodium azide in 1 00mls of PBS; 
pH 7 .4-7 .6) with optimal concentrations of FITC-labeled primary antibodies to al3-TcR, 
CD4, and CDS. The cells were stained on ice for 30 minutes. Cells w·ere then washed 
with 2ml of Staining Buffer and pelleted by centrifugation. Cells were then fixed in 
l00µL of Fixation Buffer (4g of paraformaldebyde in I00mls PBS; pH 7.4-7.6) for 20 
minutes on ice. After washing cells with Staining Buffer and pelleting by centrifugation, 
the cell pellet was resuspended in 50µL of Permeabilization Buffer (1ml FCS, 0.lg 
sodium azide, 0.Jg saponin, I00mls PBS; pH 7.4-7.6). Optimum concentrations of either 
anti-TNP-PE or anti-CTLA-4-PE mAbs were added, and the cells incubated on ice. After 
30 minutes, the cells were washed with Permeabilization Buffer, pelleted by 
centri fugation, resuspended in 1ml of Staining Buffer, and immediately analyzed on a 
F ACScan II flow cytometer (Becton-Dickinson). Twenty thousand cells were collected 
for each sample. Dead cells and debris were eliminated on the basis of forward and side 
light scatter patterns during data analysis. 
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Reverse Tmnscriptase (Rl)-PCR Analysis 
The procedure used to isolate total RNA using guanidine isotbiocyanate was previously 
described (Chomczynski and Sacchi, 1987). First-strand cDNA synthesis and PCR 
amplification were performed as previously described (Part 2, Methods and Materials, pg. 
21) except the resulting cDNA was PCR amplified for 30 cycles (94 ·c, 1 min.; 55·c; 
lmin.; 72°C, lmin. 30sec.) using murine CTLA-4 gene specific primers synthesized from 
published sequences. The CTLA -4 primers were 5' T A TT CAC A TG GAA AGC 3' and 
5' ATG GCT TGT CTT GGA C 3' and amplified a 179bp fragment (Brunet et al., 1987). 
As an internal control primers were designed to amplify the /J-actin gene as descibed in 
Part 2, Methods and Materials, pg 21. 20uL of the PCR reaction product was analyzed 
on 1.5% agarose gel and visualized by ethidium bromide. 
Proliferation Assays 
Single-cell suspensions of lymph node cells and splenocytes were cultured in 96-well 
plates in 200µL of RPM! 1640 Complete media (10% FCS) alone or in the presence of 
Concanavalin A (ConA, 5µg/ml), or phorbol 12-myristate 13-acetate (PMA, l Sng/ml) and 
calcium ionophore A23617 (Ca2• , 250ng/ml) for 48 hours at 37°C. After 48 hours of 
culture, the cells were pulsed for 8 hours with 1 µCi of [3H]thymidine. Data represent the 




Ct/a-4 mRNA Expression 
Ctla-4 mRNA has not been detected in resting T cells by Northern Blot analysis, but is 
detected within 24 hours of in vitro stimulation (Freeman et al., 1992) To detennine if 
scurfy lymphoid cells express Ctla-4 mRNA, we performed RT-PCR on unstimulated and 
ConA-activated spleen RNA using murine Ctla-4 gene-specific primers. Ctla-4 mRNA 
was not detected in wild-type unstimulated spleen, but was detectable after 48 hours of 
in vitro stimulation with ConA (Fig. 1, lanes 2 and 12). In contrast, Ctla-4 mRNA was 
detectable in both unstimulated and ConA-stimulated scurfy spleen, suggesting that Ctla-4 
is constitutively expressed in scurfy spleens (Fig. 1, lanes 4, 7, and 9). 
CTLA-4 Protein Expression 
Although CTLA-4 functions at the cell surface, it is primarily expressed intracellularly 
in activated T cells (Leung et al. , 1995). To detennine if scurfy lymph node T cells 
express CTLA-4, we analyzed non-permeabilized (surface) and permeabilized 
(intracellular) lymph node cells by flow cytometry for CTLA-4 expression. Scwfy lymph 
node et/{)-TcR+ T cells expressed significantly (p < .05) more surface CTLA-4 and 
significantly (p < .05) more intracellular CTLA-4 than wild-type controls (Fig. 2; wild-
• All figures and tables may be found in Appendix B . 
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type = 1.8% ± 2.3%; scurfy = 8.9% ± 3. I%). To determine if one of the T cell subsets 
was responsible for the increased surface CTLA-4 expression on scurfy lymph node a/~­
TcR+ T cells, we analyzed CTLA-4 surface expression on the CD4 and CD8 single­
positive T cell populations in the lymph nodes. Although barely detectable on wild-type· 
CD4+ T cells, CTLA-4 was increased 25-fold on scurfy CD4+ T cells (Fig. 3; wild-type 
= 0.2% ± 0.0; scurfy= 5.1% ± 5.4%). This increase was not statistically significant (p 
>.05) because ofone scurfy mouse expressing undetectable levels of surface CD4+CTLA-
4+. However, because of the high affinity of CTLA-4 for its ligands, it is thought that 
even minimal levels of surface CTLA-4 are physiologically significant. Similar levels of 
surface CD8+CTLA-4+ were detectable in wild-type and scurfy lymph nodes (Fig. 3; 
wild-type = 15.7% ± 2.0%; scurfy = 19.1% ± 5.5%). 
Expression of CD28, B7-1, and B7-2 by F1ow Cytometry 
rn addition to CTLA-4 expression, we analyzed the cell surface expression of CD28, the 
constitutively expressed CTLA-4 homologue. Wild-type and scurfy a /~TcR+ T cells 
demonstrated similar percentages and staining intensities for CD28 (Fig. 4; wild-type = 
72.7% ± 0.3%; scurfy= 68.6% ± 8.9%). We al so analyzed the surface expression of the 
shared CTLA-4 and CD28 ligands, B7-1 (CD80) and B7-2 (CD86). Compared to wild­
type, an increased percentage of scurfy lymph node cells appeared to express B7-1, 
although this was not statistically significant because of small sample size (Fig. 5A and 
B; wild-type 10.1% ± 8.1%; scurfy = 24.7% ± 8.5%). To determine if this apparent 
increase in B7-1 expression was due to increased percentages ofB220+ B cells expressing 
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B7-1, we double-stained lymph node cells for B220 and B7-1. By gating on B220+ B 
cells, scurfy exhibited significantly increased (p<.05) percentages of B7-1+ B cells (Fig 
5C; wild-type = 29.7% ± 5.6%; scurfy = 49.8% ± 2.8%). Additionally, significantly 
increased (p<.05) percentages of scurfy lymph node cells expressed B7-2 compared to 
wild-type control (Fig. 6; wild-type = 22.4% ± 0.5%; scurfy = 34.0% ± 3.9%). Whether 
this increased expression ofB7-2 was on B cells or activated T cells was not detennined. 
Mitogen Proliferation Assays 
To examine the functional capabil ities of scu,jY T lymphocytes, we examined their in 
vitro spontaneous incorporation of tritium and their proliferative responses to ConA and 
PMNCa2' . ConA is a selective T cell mitogen which polyclonally activates and induces 
proliferation in T cells (Sharon, 1983). In contrast, PMA, which directly activates protein 
kinase C (PKC) and calcium ionophore A23 I87, which increases cytoplasmic free 
calcium, together activate T cell s by bypassing cell surface specificity (Weiss et al., 1984; 
Truneh et al., 1985). Both scurfy lymph node cells and splenocytes demonstrated 
increased incorporation of tritium when cultured in medium alone, although because of 
variability between assays these values were not statistically significant (Fig. 7A; wild­
type = 725.9 ± 625.1; scurfy= 1227 .1 ± 1,034). Scurfy lymph node cells and splenocytes 
had decreased proliferative responses to the T cell mitogen, ConA, although only the later 
was statistically significant (Fig. 7B; wild-type = 95, 924 ± 85,899; scurfy = 21, 105 ± 
107, 417). In response to direct stimulation of PKC by PMNCa2•· both scurfy and wild­
type lymph node cells and splenocytes incorporated similar levels of tritium (Fig. 7C). 
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Appendix Expression of the CD28/CTLA-4/B7 Pathway 
Figure 1. RT-PCR analysis of Ctla-4 mRNA expression. RNA was extracted from wild­
type and scurfy unstimulated and ConA-activated spleens and subjected to RT-PCR for 
Ctla-4 mRNA expression as described in Materials and Methods. A l 80bp Ctla-4 
frat,rment was amplified in lane 4 (wild-type activated splenocytes) and 7 (scu,fy 
unstimulated spleen), and lane 9 (scurfy spar.s-efur activated spleen). Lanes 3, 5, 8, and 
IO are negative control reactions (RT" reactions). Lane 2 is a /3-actin control reaction for 
wild-type unstimulated spleen and amplifies a 1kb fragment. Lanes 1 and 6 are 
molecular weight standards (<l>x174/HaeIII). 
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Figure 2. Flow cytometric analysis of CTLA-4 cell surface and intracellular expression. 
Lymph node cells from day 19 wild-type and scurfy mice were stained for cell surface 
and intracellular CTLA-4 expression by flow cytometric analysis as described in Methods 
and Materials. A representative sample of the data is shown in (A). Histograms were 
generated by gating on a /P-TcR+ T cells and analyzing CTLA-4 expression on this 
population. The percentage of positive cells was detennined by subtraction of a negative 
isotype control and is represented by the shaded area in the histograms. Dead cells and 
debris were eliminated by gating on forward and side light scatter during data analysis. 
(B) Both surface and intracellular CTLA-4 expression are upregulated in scurfy mice 
(n=4) compared to wild-type (n=3). 
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Figure 3. Flow cytometric analysis of cell surface CTLA-4 expression on lymph node 
T cell subsets. Lymph node cells from d I 9 wild-type and scurfy mice were double 
stained for CD4 or CDS and CTLA-4 as descibed in Methods and Materials. A 
representative sample of the data is shown in (A). Histograms were generated by gating 
on CD4+ or CD8+ T cells and analyzing CTLA-4 expression on this population. The 
percentage of positive cells was determined by subtraction of a negative isotype control. 
Dead cells and debris were eliminated by gating on forward and side light scatter during 
analysis. (B) The upregulation of CTLA-4 in scurfy lymph node T cells (n=4) is 
primarily on the CD4+ T cell subset. 
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Figure 4. Flow cytometric analysis of CD28 cell surface expression . Lymph node cells 
from day 19 wild-type and scurfy mice were stained for cell surface expression of cx/13-
TcR and CD28 as described in Methods and Materials. A representative sample of the 
data is shown in (A) . Histograms were generated by gating on cx/l3-TcR+ T cells and 
analyzing CD28 expression on this population. The percentage of positive cell s was 
determined by subtraction of a negative isotype control. Dead cells and debris were 
eliminated by gating on forward and side light scatter during data analysis. (B) CD28 is 
expressed similarly on wild-type (n=3) and scurfy (n=3) lymph node T cells. 
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Figure 5. Flow cytometric analysis of B7-1 cell surface expression. Lymph node cells 
from day 19 wild-type and scurfy mice were stained for cell surface expression of B7-l 
(CD80) as described in Methods and Materials. A representative sample of the data is 
shown in (A). Dead cells and debris were eliminated by gating on forward and side light 
scatter during data analysis. (8 ) The expression of B7-l on whole wild-type and scurfy 
lymph node populations is not significantly different (p>.05). (C) But scurfy lymph nodes 
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Figure 6. Flow cytometric analysis of B7-2 cell surface expression. Lymph node cells 
from day 19 wild-type and scurfy mice were stained for cell surface expression of B7-2 
(CD86) as described in Methods and Materials. A representative sample of the data is 
shown in (A). Dead cells and debris were eliminated by gating on forward and side light 
scatter during data anlysis. (B) The expression of B7-2 on whole lymph node cell 
populations was significantly increased (p<.05) in scurfy mice (n=3) compared to wild­
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Figure 7. In vitro mitogen proliferation assays. Lymph node cells and splenocytes were 
cultured in media atone, with ConA (5ug/ml) or with PMA (15ng/ml) and calcium 
ionophore A23617 (250ng/ml) for 48 hours at 37" C, and pulsed for 8 hours with lµCi 
of [3H]thymidine. (A) Scurfy (n=9) and wild-type (n=9) lymph node cells and 
splenocytes were cultured in medium alone, and their spontaneous incorporation of tritium 
measured. (B) shows the average incorporation of tritium of scurfy (n=4) and wild-type 
(n=4) lymph node cells in response to ConA and PMNCa2• • (C) shows the average 
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The massive lymphoproliferation observed in scurfy mice suggests a breakdown in 
peripheral homeostasis and immune tolerance. The first level of immune tolerance begins 
with selection in the thymus, resulting in self-tolerant, antigenically-reactive, mature T 
cells. Previous experiments investigating thymic selection in scurfy mice did not reveal 
any gross abnonnalities (Blair et al., unpublished data). Therefore we initiated 
experiments to examine pathways known to play a role in peripheral lymphocyte 
homeostasis and tolerance, namely the Fas/FasL pathway (Part 2) and the CD28/CTLA-
4/B7 pathway (Part 3). Mice with defects in these pathways exhibit phenotypic 
similariti es to scurfy mice, suggesting that the scurfy protein may function in one of these 
known lymphoid signalling pathways (Chu et al., 1994; Takahashi et al., 1994; Tivol et 
a/., 1995). We report here that both the Fas/FasL and CD28/CTLA-4/B7 pathways are 
activated in scurfy mice, and that scurfy lymphocytes can undergo apoptosis in response 
to signalling through the Fas receptor. 
The main mechanism involved in peripheral lymphocyte homeostasis is deletion through 
apoptosis. This is achieved by the elimination of activated T cells by apoptosis at the 
conclusion of an immune response, and the elimination of self-reactive T cells in the 
periphery that have escaped thymic selection. Evidence suggests that there are two types 
of lymphocyte apoptosis involving distinct, nonoverlapping signalling pathways. The best 
characterized apoptotic pathway is the Fas/FasL pathway. This pathway plays an 
obligatory role in the activation-induced cell death (AICD) of lymphocytes in response 
to chronic activation by self or foreign antigens encountered in the periphery (Gillette­
Ferguson and Sidman, 1994). A defect in thi s pathway results in lymphoproliferation and 
autoimmune disease, characterized by the autosomal recessive mouse mutations /pr and 
gld, mutations in Fas and FasL, respectively (Chu et al., 1994; Takahashi et al., 1994). 
There is both in vitro and in vivo evidence that activation is a prerequisite for Fas­
mediated apoptosis and the decision to proliferate or die in response to TcR ligation is 
intricately tied to the differentiation and activation states of lymphoid cells (Lenardo, 
1991 ; Demiel et al., 1994). Flow cytometric analysis of scurfy T lymphocytes revealed 
evidence of previous and recent activation, characterized by the cell surface phenotype -
co44hig\ Mel-1410w, CD45RB10 w, CD69+, CD25+. The source of lymphocyte activation 
in scurfy mice is unknown. It could result from incomplete thymic selection resulting in 
the release of potentially self-reactive T cells into the periphery, or it could result from 
inadequate tennination of normal ongoing immune responses. In a nonnal state, these 
activated lymphocytes would be eliminated by Fas-mediated apoptosis. Their 
accumulation in scurfy mice suggests a potential defect in this pathway. 
In addition to activation, Fas-mediated apoptosis requires the upregulation of cell surface 
Fas and the expression of FasL (Hanabuchi et al., 1994). Northern Blot analysis detected 
increased levels of Fas mRNA in scurfy peripheral lymphoid organs, and RT-PCR 
analysis revealed constitutive expression of FasL mRNA in scurfy spleens. Constitutive 
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expression of FasL has been reported in mice with defects in the Fas-FasL pathway 
(Watanabe et al., 1995~ Chu et al., 1995). Increased levels ofFas cell surface expression 
were also observed on scurfy CD4+ and CD8+ T cells and B220+ B cells by flow 
cytometric analysis. The upregulation of Fas and FasL mRNA, and Fas cell surface 
expression in scurfy lymphoid organs is consistent with their activated phenotype, and 
suggests that the lymphoid cells accumulating in scurfy lymph nodes are primed to 
undergo Fas-mediated apoptosis. 
Although it appears that a large percentage of scurfy lymph node cells are primed for 
apoptosis, only 1.3% of freshly isolated scurfy lymph node cells were undergoing 
apoptosis in vivo. This value is not different from that observed for wild-type controls 
(1.4%). This supports our theory that scurfy lymph node cells have initiated the steps for 
Fas-mediated apoptosis, but are not completing the death program. In contrast, there was 
significantly increased percentages of freshly isolated scurfy thymocytes undergoing 
apoptosis compared to wild-type controls. However, this is most likely scurfy 
CD4+CD8+ double-positive thymocytes undergoing apoptosis in response to stress­
induced production of glucocorticoids, which proceeds by a Fas-independent pathway 
(Memon et al., 1995). This is supported by the dramatic decrease in CD4+CD8+ double­
positive thymocytes observed in scurfy mice. 
To determine if scurfy lymphoid cells are capable of Fas-mediated apoptosis, we injected 
a single large dose of purified anti-Fas mAb into wild-type and scurfy mice. Previous 
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reports have demonstrated that in vivo and in vitro treatment with anti-Fas mAb induces 
apoptosis in thymocytes, but not in the mature lymphoid populations of the lymph nodes 
and spleen (Ogasawara et al. , 1995; Trauth et al. , 1989). Our results with wild-type mice 
were in agreement with this data, with apoptosis detectable in anti-Fas-treated thymi, but 
not in anti-Fas-treated lymph nodes. In contrast, both scurfy thymi and lymph node cells 
were susceptible to Fas-mediated apoptosis. Therefore, ifprovided with the signal, scu,fy 
lymphoid cells can undergo Fas-mediated apoptosis. Why they are not undergoing 
apoptosis in vivo under physiological conditions is not clear. However, there are a 
number of possible hypothesis: (1) Scurfy mice are receiving a negative signal that is 
blocking Fas-mediated apoptosis, and the amount of injected antibody is great enough to 
overwhelm this signal. (2) Even though FasL mRNA is detected in unstimulated scurfy 
spleens, there may not be sufficient levels of cell surface FasL on scurfy lymphoid cells. 
In fact, high glucocorticoid levels have been reported to inhibit the activation-induced 
expression of FasL (Yang et al., 1995). In the absence of FasL, anti-Fas mAb induces 
apoptosis upon binding to the Fas receptor. FasL mAb is now commercially available, 
and FasL cell surface expression on scurfy lymphoid cells should be characterized. (3) 
It is also possible that scurfy have upregulated one or more lymphoid survival genes, such 
as bcl-2 or bcl-xl, both ofwhich have been implicated in blocking Fas-mediated apoptosis 
(Boise et al., 1995). 
In addition to Fas-mediated apoptosis, there is evidence for a second major apoptotic 
mechanism functioning in the periphery. This type of lymphoid death is referred to as 
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programmed cell death (PCD) and results from the lack of a costimulatory signal or from 
cytokine withdrawal or deprivation (Parijs et al., 1996). This pathway is distinct from 
Fas-mediated AfCD in that lprllpr mutants (Fas-deficient) still undergo this type of 
apoptosis. In vitro experiments in which naive murine lymph node cells were cultured 
in the absence of stimulation or exogenous cytokines, resulted in the apoptosis of a large 
percentage of lymphoid cells in both wild-type and lprl lpr mice. In contrast, naive T 
cells stimulated through their TcR and CD28, showed enhanced survival in culture, which 
was linked to the expression of bcl-xl (Parijs et al.., 1996). Bel-xi is a member of a 
family of proteins involved in promoting cell survival, and its dimerization with bax has 
been reported to prevent apoptosis (Boise et al. , 1993; Oltvai et al. , 1993). CD28 
costimulation also enhances cytokine secretion, upregulating bcl-2 expression, which has 
also been implicated in promoting cell survival (Nunez et al.., 1990). To examine this 
pathway in scwfy mutants we cultured wild-type and scurfy lymph node cells and 
thymocytes for 16 hours in the absence of stimulation or exogenous cytokines. Increased 
percentages of both scurfy thymocytes and lymph node cells spontaneously underwent 
apoptosis in culture compared to wild-type. Increased spontaneous in vitro apoptosis has 
also been reported in lpr\lpr mutants (Houten and Budd, 1992). These results suggests 
that this second peripheral apoptotic pathway is intact in scurfy mice. Scurfy mice 
overexpress a number of cytokines and the increased kinetics of scurfy spontaneous 
apoptosis may reflect rapid cytokine deprivation upon in vitro culture (Blair et al., 1994). 
Alternatively, the increased apoptosis observed in scurfy lymphoid cells could result from 
the removal of an inhibitory signal in the scurfy microenvironment. As previously 
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mentioned, scurfy lymphoid cells are phenotypically primed for Fas-mediated apoptosis, 
but we found no evidence that they are dying in vivo. Perhaps removing them from the 
scurfy microenvironment eliminates an inhibitory signal and they proceed to finish the 
apoptotic pathway. Another possibility is that in vivo, a number of cell survival proteins 
are upregulated, perhaps due to chronic stimulation through CD28, protecting these cells 
from apoptosis. When cultured in vitro, the expression of these cell survival proteins is 
rapidly lost, and the cells become susceptible to apoptosis. The rapid loss of bcl-2 
expression upon in vitro culture has been documented for murine lymphoid cells (Nunez 
et al., 1994 ). Therefore, our data suggest that the accumulating activated lymphoid cells 
in scurfy mice are primed for apoptosis, but for unknown reasons are not undergoing 
apoptosis in vivo. It is not because of an intrinsic defect in the Fas-FasL pathway that 
scurfy lymphoid cells are not undergoing apoptosis. Signalling through the Fas receptor 
with anti-Fas mAb results in rapid apoptosis in both scurfy thymocytes and lymph node 
cells. We hypothesize that apoptosis is blocked either by an inhibitory signal in the 
scurfy microenvironment, or by the upreguJation of cell survival proteins such as bcl-2 
and bcl-xl. 
CD28/CTLA-4/B7 
In addition to the Fas/FasL pathway, the CD28/CTLA-4/B7 pathway has been found to 
be involved in maintaining peripheral T cell homeostasis. The lymphoproliferative 
phenotype of mice with a null mutation in CTLA-4 revealed that CTLA-4 is not a 
redundant costimulatory receptor, but plays an obligatory role in lymphocyte homeostasis. 
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In the absence of CTLA-4, the immune system is massively activated, resulting in early 
lethality due to multiorgan lymphocyte infiltration (Tivol el al., 1995). The phenotype 
described for CTLA-4-/- mice is almost identical to that of scurfy. Therefore, it is 
possible that scurfy functions upstream or downstream of CTLA-4 in the CD28/CTLA-
4/B7 pathway. Our data demonstrates that scurfy lymphoid cells have increased 
intracellular stores of CTLA-4 protein, characteristic of activated T cells. In addition, 
scurfy T cells have increased CTLA-4 cell surface expression, limited to the CD4+ T cell 
subset. This suggests that if scurfy functions in this pathway, it is downstream of CTLA-
4 expression. There have been reports of a third CD28/CTLA-4 ligand, distinct from the 
two documented B7 ligands (Boussiois et al., 1993). The nearly identical phenotypes of 
scurfy and the CTLA-4-/- mutants implies that perhaps scurfy is this unknown CTLA-4-
specific ligand. 
Although the downstream signalling pathways ofCTLA-4 are largely unresolved, they are 
thought to involve activation of the Ras signalling pathway. The Ras pathway is 
constitutively activated in CTLA-4-/- T cells, and downstream effectors such as the 
mitogen-activated protein kinase (MAPK) are also constitutively activated in the absence 
of CTLA-4 (Marengere et al., 1996). Although Ras signalling is generally implicated in 
promoting cell survival and proliferation, it has been found to be a necessary, although 
not sufficient, step in Fas-mediated apoptosis (Gulbins et al., 1995). This implies that 
there are two distinct pathways after Ras activation: one leading to cellular activation and 
proliferation, and the other leading to apoptosis. Perhaps scurfy is responsible for 
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determining which pathway prevails after TcR ligation and Ras activation: (1) an 
inhibitory pathway characterized by negative signals through CTLA-4 and apoptosis 
through Fas~ or (2), a proliferative pathway involving positive signals through CD28 and 
the MAPKs, resulting in activation and proliferation. 
Summary 
We report here that scwfy T cells exhibit phenotypic characteristics of previously and 
recently activated lymphocytes. In addition, scwfy peripheral lymphoid cells upregulate 
both Fas mRNA and cell surface protein, and constitutively express FasL mRNA. When 
signalled through the Fas receptor, scurfy lymphoid cells can initiate Fas-mediated 
apoptosis, although why they do not in vivo is not clear. In addition, scurfy T cells have 
upregulated both surface and intracellular CTLA-4, and have increased percentages of 
lymph node cells expressing the B7-1 and B7-2 ligands. Therefore, in addition to the 
activation of the Fas/FasL pathway, scurfy have also activated the CD28/CTLA-4/B7 
pathway. This data in connection with the similar lymphoproliferative phenotypes of 
scurfy and CTLA-4-/- mice suggests that scurfy functions in the CD28/CTLA-4/B7 
pathway or an overlapping pathway. If the scurfy defect is in the CD28/CTLA-4/B7 
pathway, our data implies that the defect must lie downstream of CTLA-4 expression. 
In conclusion, we favor a scenario, parts of which are supported by the data in this report, 
in which scurfy T cells are receiving chronic signalling through CD28, resulting in the 
upregulation of cell survival proteins such as Bcl-2 and Bcl-xJ. Because of a defect in 
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CTLA-4 or an overlapping pathway, scuify T cells do not receive a down-regulatory 
signal. Scuify lymphoid cells are therefore constantly activated, resulting in cytokine 
production, B cell activation and antibody production. T cell activation upregulates Fas 
and FasL, but Fas-mediated apoptosis is blocked by the upregulation of Bcl-2 and Bel-xi. 
The accumulation of activated lymphoid cells is ultimately responsible for the cytokine 
toxicity and early lethality observed in scuify mice. Future experiments will examine the 
expression of FasL, Bcl-2, and Bcl-xl on scuify T lymphocytes in an attempt to discover 
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